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Summary 
 
 
Single-molecule microscopy is one of the decisive methodologies that allows one 
to clarify cellular signaling in both spatial and temporal dimentions by tracking with 
nanometer precision the diffusion of individual microscopic particles coupled to relevant 
biological molecules. Trajectory analysis not only enables determination of the 
mechanisms that drive and constrain the particles motion but also to reveal crucial 
information about the molecule interaction, mobility, stoichiometry, all existing 
subpopulations and unique functions of particular molecules. Efficacy of this technique 
depends on two problematic issues the usage of the proper fluorophore and the type of 
biochemical attachment of the fluorophore to a biomolecule. 
The goal of this study was to evolve a highly specific labeling method suitable for 
single molecule tracking, internalization and trafficking studies that would attain a 
calculable 1:1 fluorophore-to-receptor stoichiometry. A covalent attachment of quantum 
dots to transmembrane receptors was successfully achieved with a techinque that 
amalgamates acyl carrier protein (ACP) system as a comparatively small linker and 
coenzyme A (CoA)-functionalized quantum dots.  
The necessity of optimization of the quantum dot usage for more precise 
calculation of the membrane protein stoichiometries in larger assemblies led to the 
further study in which methods maximizing the number of signals and the tracking times 
of diverse QD types were examined. Next, the optimized techniques were applied to 
analyze behavior of  interleukin-5 β-common chain receptor (IL-5Rβc) receptors that are 
endogenously expressed at low level on living differentiated eosinophil-like HL-60 cells. 
Obtained data disclosed that perused receptors form stable and higher order 
oligomers. Additionally, the mobility analysis based on increased in number (>10%) 
uninterrupted 1000-step trajectories revealed two patterns of confined motion.  
Thereupon methods were developed that allow both, determination of 
stoichiometries of cell surface protein complexes and the acquisition of long trajectories 
for mobility analysis. 
Sequentially, the aforementioned methods were used to scrutinize on the 
mobility, internalization and recycling dynamics characterization of a G protein-coupled 
receptor (GPCRs), the parathyroid hormone receptor (PTHR1) and several bone 
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morphogenetic proteins (BMPs), a member of the TGF-beta superfamily of receptors. 
These receptors are two important representatives of two varied membrane receptor 
classes.  
BMPs activate SMAD- and non-SMAD pathways and as members of the 
transforming growth factor β (TGF-β) superfamily are entailed in the regulation of 
proliferation, differentiation, chemotaxis, and apoptosis. For effective ligand induced and 
ligand independent signaling, two types of transmembrane serine/threonine kinases, 
BMP type I and type II receptors (BMPRI and BMPRII, respectively) are engaged. 
Apparently, the lateral mobility profiles of BMPRI and BMPRII receptors differ 
markedly, which determinate specificity of the signal. Non-SMAD signaling and 
subsequent osteoblastic differentiation of precursor cells particularly necessitate the 
confinement of the BMP type I receptor, resulting in the conclusion that receptor lateral 
mobility is a dominative mechanism to modulate SMAD versus non-SMAD signaling 
during differentiation. 
Confined motion was also predominantly observed in the studies devoted to, 
entailed in the regulation of calcium homeostasis and in bone remodeling, the 
parathyroid hormone receptor (PTHR1), in which stimulation with five peptide ligands, 
specific fragments of PTH: hPTH(1–34), hPTHrP(107–111)NH2; PTH(1–14);
 PTH(1–
28) G1R19, bPTH(3–34), first four belonging to PTH agonist group and the last to the 
antagonist one, were tested in the wide concentration range on living COS-1 and AD293 
cells. 
Next to the mobility, defining the internalization and recycling rates of the 
PTHR1 receptor maintained in this investigation one of the crucial questions. 
Internalization, in general, allows to diminish the magnitude of the receptor-mediated G 
protein signals (desensitization), receptor resensitization via recycling, degradation 
(down-regulation), and coupling to other signaling pathways (e.g. MAP kinases). 
Determinants of the internalization process are one of the most addressed in recent 
studies as key factors for clearer understanding of the process and linking it with 
biological responses evoked by the signal transduction.  
The internalization of the PTH-receptor complex occurs via the clathrin-coated pit 
pathway involving β-arrestin2 and is initiated through the agonist occupancy of the 
PTHR1 leading to activation of adenylyl cyclase (via Gs), and phosphatidylinositol-
specific phospholipase Cβ (via Gq). 
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Taken together, this work embodies complex study of the interleukin-5 β-
common chain receptor (IL-5Rβc) receptors, bone morphogenetic proteins (BMPs) and 
the parathyroid hormone receptor with the application of single-molecule microscopy 
with the newly attained ACP-quantum dot labeling method and standard techniques. 
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Zusammenfassung 
 
 
 Die Einzelmolekül-Mikroskopie, das Verfolgen der Diffusion einzelner, 
mikroskopischer Partikel, welche an relevanten biologischen Molekülen gekoppelt sind, 
ist eine der entscheidenden Verfahren zur räumlichen und zeitlichen Quantifizierung der 
Zellsignalisierung und hat eine Genauigkeit im Nanometerbereich. Die so gewonnene 
Trajektorienanalyse ermöglicht nicht nur die Bestimmung der Mechanismen, die der 
Bewegung der Partikel zugrunde liegen, sondern liefert auch wichtige Informationen über 
die molekulare Wechselwirkungen, Bewegungsfreiheit und Stöchiometrie sowie über alle 
existierenden Subpopulationen und besondere Funktionen der einzelnen Moleküle. Die 
Wirksamkeit dieser Technik hängt von der Verwendung des geeigneten Flurophors und 
der Art seiner biochemischen Anhaftung  ab. 
 Das Ziel dieser Arbeit war die Entwicklung eines hochspezifischen 
Markierungsverfahrens, das zur Verwendung der Einzelmolekül-Mikroskopie für Studien 
im Bereich Endozytose geeignet ist und gleichzeitig eine Fluorophore-Rezeptor 
Stöchiometrie von 1:1 erreicht. Eine kovalente Anhaftung von Quantenpunkten an 
Membranrezeptoren wurde erfolgreich in einer Methode realisiert, die ACP-Systeme 
(Engl. Acyl-Carrier-Protein) mit Koenzym A (CoA-) funktionalisierten Quantenpunkten 
amalgamiert. 
 Die notwendige Optimierung der Verwendung von Quantenpunkten mit dem 
Ziel einer genaueren Berechnung der Stöchiometrie von Membranproteinen sehr großer 
Anzahl führte zu weiteren Studien. In diesem Zusammenhang wurden Methoden zur 
Maximierung der Signalanzahl und Beobachtungszeiten diverser Quantenpunktentypen 
untersucht. Im nächsten Schritt wurden die optimierten Verfahren angewendet, um das 
Verhalten von IL-5Rßc (Engl. Interleukin-5 ß-common chain receptor) Rezeptoren, die 
endogen auf niedriger Stufe auf lebende differenzierte eosinophile-ähnlichen HL-60 
Zellen existieren, zu analysieren. 
 Die gewonnenen Daten haben gezeigt, dass die Rezeptoren sich in stabilen 
Oligomeren hoher Ordnung bilden, was zusätzlich mit den Ergebnissen der Analyse der 
Mobilität, die auf einer hohen Anzahl unterbrochener 1000-Schritt Trajektorien basiert, 
zwei abgegrenzte Bewegungsmuster ergab. Daraufhin wurden Methoden entwickelt, die 
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eine Bestimmung der Stöchiometrie von Zelloberflächen-Proteinkomplexen und die 
Erfassung umfangreicher Trajektorien zur Bewegungsanalyse ermöglichen. 
 Im Weiteren wurden die zuvor genannten Methoden zur genauen Überprüfung 
der Mobilität, Endozytose und der Charakterisierung der rückläufigen Dynamik der 
repräsentativen Rezeptoren von zwei verschiedenen Membranrezeptoren Klassen, des 
Parathormon-Rezeptors (Engl. the parathyroid hormone receptor), der zu der G-Protein-
gekoppelter Rezeptor Gruppe (GPCRs) gehört und der Rezeptoren der 
knochenmorphogenetischen Proteine (BMPs) verwendet. 
BMPs aktivieren SMAD- und non-SMAD Signalkaskaden und als ein Bestandteil 
des TGF-β-Signalszstem sind sie in die Proliferation, die Differenyiation, die Chemotaxis 
und die Apoptose involviert. Zwei BMP Rezeptor Typen, BMP Typ I und BMP Typ II 
(BMPRI und BMPRII) sind nötig für die effektive Signalwirkung. Offenbar sind die 
Bewegungsmuster für BMPRI und BMPRII sehr unterschiedlich, was hier die 
Genauigkeit des Signals festlegt. Non-SMAD Kaskade und die nachfolgende 
Differenzierung von den Osteoblastenzellen benötigt das abgegrenzte Bewegungsmuster 
von BMPRI. Daraus folgert, dass die laterale Mobilität ein Hauptmechanismus in der 
SMAD gegen non-SMAD Signalwirkung während der Differenziation ist. 
 Das abgegrenzte Bewegungsmuster war auch für den Parathormon Rezeptor 
(Engl. the parathyroid hormone receptor) (PTHR1), der in die Calcium Homeostase und 
den Knochenumbau  involviert ist, in den Studien zu beobachten. In diesen Studien 
wurden fünf Peptide Ligande, spezifische Teile von dem PTH: hPTH(1–34), 
hPTHrP(107–111)NH2; PTH(1–14);
 PTH(1–28) G1R19, bPTH(3–34),  von denen die 
ersten vier zu der Agonistengruppe und der Letzte zu der Antagonistengruppe gehören, 
in verschiedenen Konzentrationen mit lebenden COS-1 und AD293 Zellen verwendet. 
(oder aufgebracht) 
Eine der Hauptfragen war die Festlegung der Rate der PTHR1 Internalisierung 
und des Recycling in dieser Forschung. Im Allgemeinen reduziert Internalisierung die 
Stärke der Signale, die von den G Proteinen kommen und durch die Rezeptoren 
übermittelt (die Desensibilisierung) werden. Durch den Rücklauf werden die Rezeptoren 
wieder sensibilisiert, degradiert und können somit an anderen Signalkaskaden ankoppeln 
(zB. MAP-Kinase ). 
Die Determinanten der Internalisierung sind das Hauptthema in den aktuellen Studien, 
da sie der Schlüssel zum besseren Verständnis der Internalisierung und zu den 
nachfolgenden biologischen Antworten sind. 
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Die Internalisierung von dem PTH Rezeptor verläuft entsprechend des Clathrin-coated 
Pit Weges mit der Teilnahme von β-arrestin2 und ist durch den Ligand eingeleitet, der 
zur Aktivierung von adenylyl cyclase (via Gs), und phosphatidylinositol-specific 
phospholipase Cβ (via Gq) führt. 
 Zusammenfassend ist diese Arbeit unter Verwendung von Einzelmolekül-
Mikroskopie mit der neuen ACP-Quantumpunktmethoden sowie standard 
Markierungsmethoden ein komplexes Studium über die IL-5Rßc Rezeptoren, die BMP 
Rezeptoren und den PTH Rezeptor. 
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ACP - acyl carrier protein as a covalent linkage between 
receptor and quantum dot for single-molecule studies 
 
 
 
 
 
 
Single-molecule studies reveal crucial information about mobility, stoichiometry, 
molecular interactions and the function of particular proteins. The most problematic 
issues within this technique are the proper choice of the fluorophore and the type of its 
biochemical attachment. 
A method that attains a highly explicit linker of comparatively little size and calculable 1:1 
fluorophore-to-receptor labeling stoichiometry was evolved that amalgamates usage of 
acyl carrier protein (ACP) and coenzyme A (CoA)-functionalized quantum dots. This 
strategy enables to affix quantum dots covalently to transmembrane receptors and is 
therefore highly useful for single molecule tracking, internalization and trafficking 
studies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biotechniques. 2010 Aug; 49(2):574-9 
Zelman-Femiak M, Wang K, Gromova KV, Knaus P, Harms GS 
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1.1. Introduction 
 
 
 
Signal transduction cascades are initiated by and depend ulitimately on specific 
protein interactions in the plasma membrane. The most common trigger for the complex 
cellular responses is at first binding of a ligand to a receptor which next activates 
downstream signaling pathways. The study of the early events in the signaling cascades 
seems to be crucial issue to fully realize these processes. In order to gain more detailed 
information about dynamics and character of the membrane receptor interactions it is 
essential to follow the processes at a single-molecule level in real-time. Single-molecule 
microscopy is one of the decisive methodologies that allows to clarify cellular signaling in 
both spatial and temporal dimentions. Single-molecule microscopy not only enables 
determination of the protein interactions but also their motion, local stoichiometry, 
existing subpopulations and unique functions of particular molecules. Two issues that 
may affect efficacy of this technique are the usage of the proper fluorophore and the type 
of its biochemical attachment (1-4). 
For the purpose of analyzing molecular mobility and determining specific 
localization of particular molecules high signal-to-background ratios and acquisition rates 
as well as inflexible, of a minimal size fluorophore are required (5,6). Fluorescent fusion 
proteins are frequently used for receptor labeling in single-molecule studies (7-10). 
Fluorophores are then covalently bound to cysteine or amino reactive groups of the 
receptor. Alternatively, small protein tags for the link between the dye and the membrane 
protein are applied (11).  
Currently, next to labeling with standard organic fluorophores, labeling 
techniques with quantum dots (QD) are ascertained. Quantum dots have definite 
advantages over organic dyes as they produce much stronger fluorescence signals and 
have increased resistance to photobleaching. Concerning the size of QDs, they are 
approximately ten times smaller than latex beads and nearly the size of fluorescent 
proteins (12,13). 
Most commonly used are quantum dots conjugated to antibodies (1,3), what adds 
to the radius of the QD approximately 10nm (1,3,4), influences registered motion and 
interferes with acquiring precise data. Maintained is then the wish of decreasing the 
linkage for the quantum dot labeling system and to overcome difficulties that long-tailed 
attachment introduces (14-17). Conjugation of the quantum dots to primary Fab 
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fragments shows already signs of a substantial improvement. However, still infant are 
direct QDs binding and labeling methods of the receptors (1-4). They can be attained by 
amino or cysteine reactions or by exposing the biotinylated membrane protein to either 
quantum dots coated with streptaidin or to its truncated version, m-streptavidin that 
consists of 159 amino acid residues (18,19). An alternative scheme for direct labeling 
represents a fusion protein that includes a HaloTag, which is 296 amino acid 
modification of haloalkane dehydrogenase and is capable to creat a covalent binding with 
a chloroalkanelabeled quantum dot (20,21). 
Despite of existing a wide variety of labeling techniques which can be applied for 
biological imaging and receptor analysis (22-24), chiefly are those noncovalent or 
inapplicable for quantum dot labeling. However, a bunch of stabile methods with organic 
fluorophores found application in single-molecule microscopy, for instance, 
hexahistidine (13,26,27), FlAsH (25), Q-tag (29) and biotin acceptor peptide exist (28).  
 Effective labeling and tracking of single receptors on living cells enables the 77 
amino acid acyl carrier protein (ACP) which can be reacted with coenzyme A (CoA) 
coupled to organic dyes or biotin (30) in the presence of phosphopantetheinyl transferase 
(PPTase) as a catalyst. ACP is smaller than similar SNAP and CLIC tags (22-24), and its 
fusion maintains the biological activity of receptors. Additonally, ACP binds CoA in a 
covalentlike manner what guarantee specificity and effectiveness of this reaction. Benefits 
of tracking and conducting internalization studies with ACP-CoA and organic 
fluorophores were presented on G protein-coupled receptors (GPCRs) (9,10) and AMPA 
receptors (31). Unknown, so far, has been a protocol for the direct QD labeling of the 
receptors containing the ACP tag.  
In this study a QD-ACP labeling method is presented. The QDs attach 
covalently to the CoA molecules through activated thiol groups. A 1:1 QD:CoA ratio is 
provided due to the presence of amine blocking groups applied beforehand on the 
containig free amine groups quantum dot coating layer. The efficacy of the QD-ACP 
labeling technique is shown on the parathyroid hormone receptor (PTHR) and the bone 
morphogenetic protein type II receptor (BRII). For proper comparison each of the 
receptors are tracked and labeled also with antibody QD conjugates. We demonstrate 
that ACP-CoA-QD labeling system as the shortest specific covalent quantum dot 
tethering system, allows more precise tracking, elongated tracking times and 
determination of behaviour of particular receptors at the membrane, during 
internalization and postinternalization trafficking events.  
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1.2. Results & Discussion 
 
 
 
Recently multiple labeling methods involving covalent attachment of 
fluorophores have been devised. The goal of this study was to invent a direct and 
uncomplicated QD labeling technique utilizing possibly short QD tether to amend 
tracking, internalization and visualizing trafficking events of particular receptors. We 
contrived a system based on the ACP, already known an extracellular fusion protein tag 
for receptors (30). First, to enable QD covalent binding to the ACP, QDs had to be 
coupled to CoA. We applied commercially available quantum dots that comprise of 
nanometer-scale CdSe core coated with an additional ZnS semiconductor shell and 
further with a polymer shell with extraneous free amine groups, which sequentially we 
blocked with a befitting concentration of amine blocking groups. Final, thiol-reactive 
chemistry resulted in obtaining QD-CoA with 1:1 ratio. (Figure 1A). 
 
 
 
 
Figure 1A. The QD blocking and functionalization to the CoA. The majority of free amines 
on the QDs are blocked with the t-Boc. The remaining amines are functionalized with the 
SMCC so that at most, only one SMCC is functionalized to a QD. The CoA is then directly 
linked to the QD from the direct maleimide-thiol reaction. 
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Figure 1B. Schematic diagram of labeling technique. By application of the enzyme 
PPTase, a single QD-CoA is transferred to the ACP protein fused to the receptor (ia,ib). 
Additionally, the small 77-amino acid sequence added to the receptor’s extracellular domain 
is shown here (ib). 
 
Next, the binding specificity of CoA-QDs to ACP-receptor under conditions of 
the enzymatic reaction with PPTase was examined (Figure 1B). We chose two membrane 
receptors to be ACP extracellularly tagged: a truncated PTHR (32) and a truncated BRII 
(33, 34), termed ACP-PTHR-TC and ACP-BRII-TC1, respectively. ACP-BRII-TC1 is 
the shortest BRII mutant which has the stop codon inserted directly before the kinase 
domain and lacks nearly all of the cytoplasmic tail of the receptor. The ACP tag is fused 
at the N terminus of the BRII-TC1. ACP-PTHR-TC corresponds to the PTH type 1 
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receptor lacking transmembrane domains III to VII and the 150-amino acid C terminus 
and has ACP crammed in the N-terminal ligand binding region.  
HEK293 cells transiently transfected with appropriately low amounts of either 
ACP-PTHR-TC or ACP-BRII-TC1 after CoA-QD labeling exhibited the receptors 
efficiently and with the intensity applicable for the single molecule tracking at the plasma 
membrane (Figure 2, A and B). To affirm the explicitness of the ACP reaction we 
utilized solely CoA-QDs without the PPTase enzyme on the transfected HEK293 cells. 
No attachment of CoA-QDs was observed (Figure 2, A and B). A similar outcome, even 
upon the PPTase application, was achieved with nontransfected cells. Evidently, the 
signals registered on the transfected cells derived from the quantum dot labeled receptors 
(Figure 2C). 
Besides verifying the specificity of our method, we also intended to make a 
comparison between the efficiency of CoA-QD system and labeling with antibody 
conjugated QDs on the transfected cells. For that reason the QD-CoA-ACP-labeled 
receptor was juxtaposed with the extracellularly HA-tagged BRII-TC1 (33,34) stained 
with mouse anti-HA primary and anti-mouse-Fab-QD-conjugated secondary antibody. 
The average number of receptors per cell appeared to be similar in both cases (Figure 2, 
B and D). 
 
     A                                     B                                    C                                   D  
 
 
Figure 2. Characterization of the ACP-CoA-QD labeling of receptors on living cells. 
Fluorescent images are shown at the bottom and the corresponding transmission images are 
presented above. (A) CoA-QD labeling of HEK293 cells transfected with ACP-PTHR-TC 
followed by PPTase treatment displays many QDs (bottom left). Non–PPTase-treated cells 
show no QDs (bottom right). (B) CoA-QD labeling of HEK293 cells transfected with the ACP-
BRII-TC1 plasmid followed by PPTase shows many QDs (bottom left), while without PPTase 
treatment, there are no QDs (bottom right). (C) Negative control of nontransfected HEK293 
cells without (left) and with (right) CoA-QD and PPTase treatment. (D) Antibody-QD labeling 
of transfected HEK293 cells (transmission image, top) with the HA-BRII-TC1 plasmid with 
both the primary anti-HA antibody and secondary Fab antibody QD conjugate showing many 
QDs (bottom). All intensity scaling is in photons/5 ms. 
 
Next, we tracked ACP-PTHR-TC marked covalently with CoA-QD on living 
cells. Whereas the data on the diffusion of the whole length PTHR receptor were known 
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(37), the type of the mobility and the role of this intensely truncated receptor were not 
determined. We applied TIRF microscopy to image the receptors on the basolateral 
surface of cells (Figure 3A). During tracking, we could pinpoint long (>50 step) traces of 
singular QD-receptor complexes, initially signifying free diffusion both before and after 
PTH addition, with subsequent fast internalization (Figure 3B, ia and ib). A small 
subpopulation of QD-receptor complexes exhibited limited mobility as well without as 
with ligand stimulation and mostly lasted long before internalizing or did not undergo 
internalization at all (Figure 3B, iia-iic). The movement of each individual QD-receptor 
complex was analyzed before and after ligand application to define the average motion 
(Figure 3C). Before PTH addition the QD-receptor complexes diffused in a partially 
confined manner on the membrane with a diffusion coefficient of 0.014 ± 0.002 µm2/s 
and a confinement coefficient c = 0.739 ± 0.041. The QD-receptor complexes that 
endured at the membrane >10 min after PTH application displayed slow movement with 
the average motion of 0.00033 ± 0.00005 µm2/s, what corresponds with the values 
barely above of the ascertained positional accuracy. 
 
 
 
 
Figure 3A-B. Tracking of the surface mobility and internalization of ACP-PTHR-TC in 
live HEK293 cells. (A) Transmission (upper) and TIRF images (lower) of the CoA-QD-
labeled ACP-PTHR-TC on HEK293 cells (left). Two traces in a magnified portion of the left 
image are shown in red and green (right). (B) Traces and plots of mean square displacement 
(MSD) versus time lag for each track of the two individual QD-receptor clusters from panel A. 
Before ligand addition, the receptor (i) was freely but slowly mobile (0.003 ± 0.001 µm2/s) and 
became more mobile (0.021 ± 0.005 µm2/s) 2 min after addition of 2.5 nM PTH. Zero, 5, and 
10 min after PTH addition, the receptor (ii) displayed extremely confined motion (0.0002 ± 
0.0001 µm2/s, 0.00083 ± 0.00008 µm2/s, and 0.00005 ± 0.00001 µm2/s, respectively). 
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Figure 3C-F. Tracking of the surface mobility and internalization of ACP-PTHR-TC in 
live HEK293 cells. (C) The average motion was determined by probability analysis (see the 
“Materials and methods” section) and plotted as MSD versus time lag. The motion before 
PTH addition (t = 0 min) is indicated by the solid line with dark circles and after PTH addition 
by the dotted line with open circles. (D) Four images acquired at 2, 5, 10, and 15 min after 
ligand application display the internalization behavior for the zoomed image from panel A. (E) 
Temporal statistics from more than 10 cells for the internalization of ACP-PTHR-TC after 
addition of 2.5 nM PTH. (F) Trafficking of ACP-PTHR-TC receptor from the membrane into 
the cell. Overlay fluorescence and transmission image of four QD-receptor complexes with 
one trace showing two consecutive steps from the membrane (first image). Zoomed images 
(right three) of the QD-receptor complex at the membrane in the first image of the sequence 
with the same trafficked receptor complex (second image) and 2 and 3 min later (third and 
fourth images). Intensity scaling in panels A and D is in photons/5 ms. 
 
 
 
Due to the ~1 order of magnitude difference in length between the shorter ACP-
CoA-QD and the longer anti-HA/antimouse-Fab-QD labeling, we decided to compare 
the motion of the receptors marked with each of the methods. The ACP-BRII-TC1 and 
HA-BRII-TC1 were tracked on cells before and after addition of BMP-2. In the absence 
and presence of ligand, the ACP-BRII-TC1 and HA-BRII-TC1 showed freely diffusing 
behavior (Figure 4, A and B) until just before the receptors internalized, whereupon the 
motion either significantly slowed Dlat, ACP, 10 min after = 0.0004 ± 0.0002 µm
2/s or became 
confined to regions of ~270 ± 20 nm in diameter. Noticeably, the diffusion trajectories 
from the HA-tagged and anti-HA/antimouse-Fab-QD labeled receptors invariably 
seemed to exhibit a larger movement, which, however, did not lead to a significant 
enlargement of the diffusion coefficient of the average mobility behavior (Figure 4B), 
where before BMP-2 application Dlat, ACP, before = 0.014 ± 0.002 µm
2/s and Dlat, HA, before = 
0.018 ± 0.004 µm2/s. 
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Figure 4. Tracking and internalization of the BRII-TC1 receptor on HEK293 cells. (A) 
Comparison of tracking from QD-receptors with ACP-CoA-QD labeling (upper) and HA/anti-
HA/anti-mouse-Fab-QD labeling (lower) with MSD versus time lag plotted for each track after 
addition of 1 nM BMP-2. (B) The average motion was determined by probability analysis (see 
the “Materials and methods” section) and plotted as the MSD versus time lag of all ACP-
BMPII-TC1 (top graph) and HA-BMPII-TC1 (lower graph) receptors before (dotted line with 
open circles) and after (solid line with dark circles) ligand addition. (C) Transmission (first 
image) and TIRF images (right four) of the CoA-QD ACP-BRIITC1 on HEK293 cells acquired 
at 0, 7, and 15 min after 1 nM BMP-2 addition (right three magnified images are of the same 
region at t = 0, 7, and 15 min) to display the internalization behavior. Intensity scaling is in 
photons/5 ms. (D) Temporal statistics from >10 cells for the internalization of ACP-BRII-TC1 
after 1 nM BMP-2 addition. 
 
We investigated the internalization actions of both ACP-QD-labeled receptors as 
next. The analysis of the TIRF and wildfield images of the basolateral surface of the cells 
was conducted for instances when a QD-receptor complex would internalize and vanish 
from the membrane in longer timelapse sequences. Figure 3D and Figure 4C present 
examples of time-lapse internalization of the ACP-PTHR-TC and the ACP-BRII-TC1, 
respectively. Despite the fact that all QD-receptor complexes in the example displayed 
for ACP-PTHR-TC (Figure 3D) internalized, on average only 60% of receptors 
completely internalized with a single exponential rate of ~0.1 QD-receptor complex per 
minute (Figure 3E). More than 80% of the ACP-BRII-TC1 QD-receptors internalized 
with an aevident bi-exponential rates of 0.1 and 1 QD-receptor complex per minute 
(80% and 20%, respectively; Figure 4D). Recycled QD-receptors were observed in all 
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cases (Figure 4C and Figure 5), however, any of the recycled receptors was included in 
the determination of internalization rate. Besides internalization rates, the technique is 
also applicable for larger scale trafficking events with broader imaging fields and 
increased penetration depths with slightly lower magnification and numerical aperture 
objectives. Numerous examples showed clearly that the receptor at the membrane could 
be tracked for internalization into the cells (Figure 3F). 
 
Figure 5. Internalization of the ACP-PTHR-TC and the ACP-BRII-TC1 receptors in living 
HEK293 cells. (A) Transmission (top left) and six TIRF images of the QD-CoA–labeled ACP-
PTHR-TC acquired with lapsed time of 0–15 min after 2.5 nM PTH addition to display the 
internalization and recycling behavior for images from 3 A and D. (B) Transmission (top right) 
and fluorescence images of the CoA-QD ACP-BRII-TC1 on HEK293 cells (right) acquired 
before (t = 0 min) and after 1 nM BMP-2 with lapsed time of 2–15 min to display the 
internalization behavior (from Figure 4C). 
 
 
In this study, we demonstrated our labeling method on decoy versions of the 
PTH and BRII transmembrane receptors, which both contain the ligand binding site but 
are deficient of the intracellular domain indispensable for signaling. The ACP technique 
provided efficient and highly specific labeling, what together with the excellent stability 
of the QDs enabled to perform internalization analysis of the receptors with minute 
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timescale time-lapse imaging to discern trafficking of individual receptors from the 
membrane into the cell and to also monitor recycling rates.  
The tracking of the receptors showed that ACP-QD labeling characterized 
slightly lower mobility than antibody-QD labeling. We elucidate reduced mobility as the 
consequence of the shorter linker between the receptor and QD. Besides QD-receptor 
linkage, also truncation of the receptors could influence their movement. High and free 
diffusion mobility was expected from the truncated receptors, particularly when 
compared to studies carried out on the full-length PTHR and BRII (37) however, 
truncated receptors displayed only moderate but still free diffusion. Without BMP-2 
stimulation a free diffusion of the ACP-BRII-TC1 was observed that support the 
observation that it does not bind to other receptors in the absence of the ligand 
(33,34,38). Ligand application resulted in incomplete internalization of the ACP-PTHR-
TC receptor what agreed with data previously gathered on truncation mutants of this 
receptor (39). Ligand addition caused nearly complete internalization of the ACP-BRII-
TC1, which can be explained by binding to the epidermal growth factor pathway 
substrate 15 related protein (EPS15R), which is constitutively present in clathrin-coated 
pits (CCPs), the main internalization route of BRII (33).  
We propose that binding to EPS15R steers the ligand-activated BRII-TC1 into CCPs, 
yielding in reduced mobility of the receptor, confinement to a region the size of CCPs, 
and the almost full internalization of this decoy receptor. 
In the further projects, the ACP-QD labeling technique can be useful in the 
mobility analysis, internalization dynamics and trafficking studies of the wide variety of 
the membrane receptors as well as their specific signaling mutations. With the usage of 
the newly described 12–amino acid CoA binding domain (40,41) and recently delineated 
smaller and biologically benign QDs and nanoparticles (12,13,18) ACP-QD labeling can 
become the smallest, brightest, most specific, and most stable covalent labeling for 
tracking, internalization, and trafficking studies of individual receptors, what in 
combination with recently reported methods for 3-D tracking (42) would make it 
possible to determine the entire fate of individual receptors. 
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1.3. Materials and methods 
 
 
 
1.3.1. Plasmid construction of ACP-PTHR-TC and ACP-BRII-TC1 
Conflating the ACP to the N terminus of truncated human parathyroid hormone 
receptor PTHR-TC or to the N terminus of the truncated human type II bone 
morphogenetic receptor BRII-TC1 was generated analogously to priorly described N-
terminally tagged GFP-PTHR (32) or BMP-HA and –myc receptors (33,34). 
The PCR products of ACP and respective protein fragments were subcloned into 
pcDNA3 (Invitrogen, Karlsruhe, Germany) resulting in final constructs as follows: the 
ACP-PTHR-TC consisted of truncated (102-270 aa) and not embracing 
pharmacologically insignificant residues 61-101 human PTHR, besides of two residues 
(from restriction sites) between the ACP C and the PTHR-TC N terminal tails and six-
residues between the ACP N terminal tail and the signal peptide of PTHR.; the ACP-
BRII-TC1 contained six-residues between the ACP C and the BRII-TC1 N terminal tails. 
All constructs were verified by sequencing. 
 
1.3.2. Cell culture 
HEK293 cells were grown at 37oC/5% CO2 in DMEM solution (Sigma-Aldrich, 
Taufkirchen, Germany) with addition of 10% FCS (PAA Laboratories GmbH, Linz, 
Austria) and 1% penicillin/streptomycin (Sigma-Aldrich). For single-molecule imaging, 
cells were seeded into six-well plates containing glass coverslips (No. 1, round, 24 mm; 
Assistent, Sondheim, Germany). Cell transient transfections were performed with 
FuGENE 6 (Roche Applied Science, Indianapolis, IN, USA) or Effectene (Qiagen, 
Hilden, Germany) and application of 0.2 µg plasmid DNA per well. 
 
1.3.3. Labeling 
For labeling cells were incubated on the coverslips for 15–20 min at 37oC/5% CO2 in 
270 µL DMEM with 1% BSA (Sigma-Aldrich), 1.5 µM 6xHis- phosphopantetheinyl 
transferase (PPTase), and 0.3 nM CdSe/ZnS quantum dot-coenzymeA (QD-CoA) 
molecules conducted with the QD655 Qdot Antibody Conjugation Kit (NrQ22021MP; 
Molecular Probes, Invitrogen Detection Technologies, Eugene, Oregon, USA; 
Invitrogen, Karlsruhe, Germany) and conjugated with CoA (Sigma- Aldrich). 
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Tending to establish 1:1 CoA:QD ratio, t-Boc protective groups were used to block 
unreacted amine groups within the coating phase of 655 quantum dots. The quantity of 
free amines occured to vary, thus the concentration of t-Boc was roughly estimated to 
proceed blocking in a way that statistically most of the quantum dots swilled from 
equivalently transfected cells. That indicated smaller than 1:1 CoA:QD ratio. Amines 
which did not undergo the reaction with Di-tert-butyl dicarbonate (Sigma-Aldrich) were 
exposed for reacting with lower molar ratios of succinimidyl 4 [N-maleimidomethyl] 
cyclohexane-1-carboxylate (SMCC; Perbio Science, Bonn, Germany). The melamide-QD 
was then conjugated to CoA (Figure 1A). Mentioned reaction steps were performed not 
only with 655 quantum dots but also with QD585 QDot Antibody Conjugation Kit 
(NrQ22011MP) and with the amine-reactive 520 nm Adirondack Green and 600 nm 
Fort Orange EviTags QDs from Evident Technologies (Troy, NY, USA). The PPTase 
plasmid was acquired from Kai Johnsson (University of Lausanne, Lausanne, 
Switzerland). Production and purification of the PPTase protein was conducted 
resembling previously published protocols (1).  
Three times washing step with 500 µL DMEM followed staining samples with quantum 
dots. During experiments cells were kept in 300 µL DMEM. 
The hydrodynamic radius of 655 quantum dots was appraised between 15-20 nm. The 
coenzymeA seemed to extend the length of the radius about 1–2 nm.  
 
1.3.4. Ligands 
Human parathyroid hormone peptide ligand hPTH, amino acids 1–34 (Bachem 
California, Torrance, CA, USA) was applied to bind the truncated human parathyroid 
hormone receptor. Human bone morphogenetic protein-2 (BMP-2; Sigma-Aldrich) was 
used to bind the truncated BRII-TC1. Ligands were diluted in PBS and added in 
concentrations from 1 nM to 10 nM, depending on the experiment. 
 
1.3.5. Single-molecule microscopy 
The experimental arrangement for single molecule imaging has been described in detail 
previously (35,36). Essentially, the samples were mounted onto an inverted microscope 
(Axiovert 200; Zeiss, Götingen, Germany) equipped with a 100x objective (PlanNeofluor 
100x, N.A. = 1.3; Zeiss), and illuminated for 5 ms with the 473-nm laser line of a diode 
laser (MBL-473-100; CNI Laser; Changchun, China) with excitation intensity of 0.5–1 
kW/cm2 and synchronized with the exposure of the Peltier-cooled electron-multiplying 
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charge-coupled device (EMCCD) camera system (CascadeII 512B; Roper Scientific, 
Tucson, AZ, USA). The synchronization was realized by the use of home-built 
electronics to set the exposure trigger from the CCD camera and an acousto-optic time-
frequency shutter (AOTF; AA Opto Electronic, Orsay, France) to control the laser light 
excitation. This system provided exact timing of the illumination time, intensity, and 
wavelength. Fluorescence signals from the QDs were monitored through a dichroic 
mirror (DCLP525; Chroma, Bellows Falls, VT, USA) in combination with a band pass 
(HQ655/40 nm; Chroma). The total detection efficiency of the experimental setup was 
13% for the QDs (QD655). Typically, 500 readouts of half the region of the full array 
(256 x 256 pixels in the image plane) of the CCD chip was acquired to the PC with a time 
interval of 27 ms. During the experiment time, the cells were kept at 37oC via an 
objective heater (Bioptechs, Boulder, CO, USA). 
 
1.3.6. Total internal reflection single-molecule microscopy 
The total internal reflection (TIRF) single-QD imaging and tracking were performed on a 
Leica AM TIRF system (Leica, Wetzlar, Germany). The TIRF microscope was 
customequipped from the manufacturer with a 100×, N.A. = 1.46 objective (Leica), a 
405-nm, 50-mW diode laser (CUBE; Coherent, Santa Clara, CA, USA), and the EMCCD 
camera system (CascadeII 512B). The TIRF angle was adjusted electronically via software 
control down to penetration depths of 70 nm. The emission of the QDs was filtered with 
a custom inserted band pass filter (HQ655/40 nm; Chroma). 
 
1.3.7. Data analysis 
Data processing occurred in Matlab (MathWorks, Natick, MA, USA). Trajectories were 
constructed from the positional shifts of the QDs in consecutive images and analyzed 
following a method as described (8). For the analysis of the (ri 
2, tlag) plots, a positional 
accuracy of 7 ± 2 nm in our measurements was considered, and results in a constant 
offset in ri 
2 of 0.000049 µm2 for all time lags (5). In brief, the lateral diffusion of 
Brownian particles in a medium characterized by a diffusion constant D is described by 
the cumulative probability distribution function for the square displacements, r2 (43): 
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P(r2, tlag) describes the probability that the Brownian particle starting at the origin will be 
found within a circle of radius r at time tlag. Provided that the system under study 
segregates into two components, characterized by mean-square displacements r1 
2 and r2
 2, 
and relative fractions α and (1 – α), respectively, Equation 1 becomes (8,43): 
 
The cumulative probability distributions P(ri 
2, tlag) were constructed for each time lag 
from the single-molecule trajectories by counting the number of square displacements 
with values <r2, and subsequent normalization by the total number of data points (43). 
Probability distributions with n >1000 data points were least-square fit to Equation 2, 
resulting in a parameter set {r1 
2(tlag), r2 
2(tlag), α}, for each time lag, tlag, between 0.027 and 
1.6 s. This approach of fitting leads to a robust estimation of the mean-square 
displacements ri 
2 even when the mobility is not purely random (8). Examples of the data 
acquired can be found in Figure 6. 
 
 
Figure 6. Examples of mobility probability distribution functions described above for 
the trajectory analysis. (A) Example from ACP-PTHRTC 10 min after PTH at tlag = 0.66 s. 
(B) Example from ACP-BRII-TC1 before BMP-2 addition at tlag = 1.32 s. (C) Example from 
HA-BRII-TC1 before BMP-2 addition at tlag = 0.33 s. 
 
1.3.8. Mobility analysis 
By plotting the mean square displacement (ri 
2) versus tlag, the diffusional behavior of the 
respective populations of molecules is revealed. The (ri 
2, tlag) data sets were fitted by a 
free diffusion model, 
 
where ri 
2 is proportional to time tlag. When diffusion is hindered by obstruction or 
trapping in such a way that the mean square displacement is proportional to some power 
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of time <1 (ri 
2 ~ tα , α < 1), it is called anomalous subdiffusion, and the diffusion 
constant becomes (8): 
 
If α = 1, then ri
 2 ~ 1, D = Γ is constant, and diffusion is normal. When the meansquare 
displacement does increase with time but levels of to a constant value for longer time 
lags, this was described with a confined diffusion model. The confined diffusion model 
assumes that diffusion is free within a square of side length L, surrounded by an 
impermeable, reflecting barrier. Then the mean-square displacement depends on L and 
the initial diffusion coefficient D0, and varies with tlag as (8,6): 
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 2  
 
 
BMP type I and II receptors mobility linked to  
non-SMAD/SMAD signaling 
 
 
 
 
 
 
Bone morphogenetic proteins (BMPs) are members of the transforming growth 
factor β (TGF-β) superfamily and are entailed in the regulation of proliferation, 
differentiation, chemotaxis, and apoptosis (1). BMP signaling engages two types of 
transmembrane serine/threonine kinases, BMP type I and type II receptors (BMPRI and 
BMPRII, respectively). BMPs activate SMAD- and non-SMAD pathways and can educe 
a wide variety of biological responses. In this investigation the question about 
involvement of BMP receptors in the specificity of ligand-induced responses was tackled. 
Single-molecule microscopy revealed an apparent divergence in the mobility of 
BMP receptors type I and type II. In further experiments the difference in motion of the 
receptors was juxtaposed according to the BMP signaling routes. The necessity of the 
confinement of BMP type I receptor was recognized for non-SMAD signaling and 
ensuing osteoblastic differentiation of precursor cells. 
The conclusive postulate has been made that receptor lateral mobility navigates 
through SMAD versus non-SMAD signaling during differentiation. 
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2.1. Introduction 
 
 
 
Bone morphogenetic proteins (BMPs) embrace the vastest assmeblage of the 
transforming growth factor β (TGFβ) superfamily and actively participate in embryonic 
patterning and organogenesis (2,3), adult tissue homeostasis and regeneration (4,5,6). 
There have been four of type I and three of type II BMP receptors identified so far (7). It 
is also known that for effective signaling both type of receptors, that together create 
heterotetrameric complexes, are essential. After ligand is chained, sequentially BMP 
receptor type II (BMPRII) transphosphorylates BMP receptor type I (BMPRI) which in 
response phosphorylates the intracellular signaling proteins that belong to either SMADs 
or are members of mitogen-activated protein kinase (MAPK) pathways. This enables the 
initiation of respective SMAD and non-SMAD signaling cascades (8). 
Multiplicity of biological processes that can be triggered through BMPs is still 
one of the most mystrious and fascinating riddle in the field. Some of factors that 
influence flow of the signal have already been found. One of the examples is the BMP 
ligand-receptor oligomerization which occurs in two different ways (9). The ligand can 
either target a preformed type I/type II heteromeric receptor complex (PFC) which 
show next a preference for SMAD-signaling. Alternatively, it can affix to its high affinity 
type I receptor guiding to recruitment of the type II receptor and formation of a BMP-
induced signaling complex (BISC) that activates non-SMAD pathways such as MAPK 
cascades (10). 
The course of signaling and internalization of BMP receptors can be also affected 
through the receptor localization within particular plasma membrane domains (11,12). 
Moreover, the discrepancy in the binding affinity of BMPs to recpetors type I and II has 
been shown indicating analogously strong affinity of BMP-2 for BMPRIa and BMPRIb 
(KD BMPRIa > BMPRIb >> BMPRII) but perceptibly higher affinity of growth 
differentiation factor 5 (GDF-5), another member of the BMP family, for BMPRIb than 
for BMPRIa (KD BMPRIb >> BMPRIa > BMPRII) (13).  
However, still many questions regarding BMP signaling machinery stay open. 
Single-molecule tracking could help to clarify and understand the goverence of the BMP 
signals by observation of the individual BMP type I and II receptors in the context of 
their natural environment. Behavior of the receptors can be observed gradually, 
commencing with the absence of activatory ligand, during activation and finally 
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internalization. Single-molecule microscopy has already furnished insights into assembly 
and activation of signaling molecules such as EGFR (14). Varried mobility pattern before 
and after activation was presented for particular signaling molecules, e.g. the Ras 
molecule, and attributed to gathering of signaling complexes (15). Observed dwindling 
motion of TGFβ receptor type I after TGFβ stimulation seemed to match its 
heteromeric congregating with type II receptors (16). 
In this study, the single-molecule microscopy has allowed to examine influence of 
receptor motion on the signaling pathways and to evince that lateral mobility of BMP 
receptors depends on the transmembrane domain and is essential for govering the 
SMAD- versus non-SMAD signaling under BMP stimulation. 
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2.2. Results & Discussion 
 
 
 
2.2.1. BMP receptors type I and II have different lateral mobilities   
Fluorescence recovery after photobleaching (FRAP) was applied to C2C12 cells 
expressing BMPRIa-YFP and BMPRII-CFP fusion constructs to examine diffusion of 
BMP receptors in living cells. FRAP analysis showed the recovery rate to differ and be 
double higher for BMPRII than for BMPRIa, what immediately indicated that receptor 
type I consists of bigger immobile subpopulation that decreases its total lateral diffusion 
(Figure1a). Gathered data are in agreement with the previously presented fact that 
BMPRIa receptors strongly associate with DRM (11). Additionally, acceptor 
photobleaching exhibited a noticeable CFP increase for a FRET efficiency of 36% what 
clearly implies that BMPRIa receptors affiliate with BMPRII before ligand addition. This 
provides another convincing evidence for ligand independent so-called preformed 
complexes (PFCs). 
Next, single-molecule microscopy was utilized to study mobility of BMP 
receptors labeled with two separate methods: 1) enzyme-mediated quantum dot (QD) 
labeling of acyl carrier protein (ACP)-tagged receptors (17) and 2) antibody-mediated QD 
labeling of HA- or Myc-tagged receptors.  
Traces of individual QD labeled receptors and analysis of their mean square 
displacement (MSD) showed that BMPRIa and BMPRIb display mainly confined motion 
with a confinement size of < 100 nm (Figure 1b,c), what closely correlates with the low 
recovery rate and domination of immobile BMPRIa component in FRAP experiments. 
Importantly, both labeling techniques, ACP- and antibody-mediated led to the same 
result and no apparent discrepancy has been noticed between them (17). That puts the 
BMPRI membrane localization to be the main restrictive factor in receptor mobility. 
BMPRII displayed two subpopulations with divergend mobility pattern, of which 
one showed a confined motion within regions of 200 nm or smaller (Figure 1e,f) 
mirroring the movement of BMPRIa and BMPRIb with diffusion coefficients of 0.004 
µm2/s. Whereas the other subpopulation of much longer traces fits a free diffusion 
model in the mean square displacement (MSD) analysis (18) (Figure 1e,f) and reflects the 
high recovery rate in FRAP experiments (Figure 1a). 
Again, results for ACP- and antibody-mediated labeling methods did not show any 
marked differences.  
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Figure 1. BMP receptors type I and II have different lateral mobilities. 
(a,b) Analysis and images of fluorescence recovery after photobleaching (FRAP) and 
fluorescence resonance energy transfer (FRET). Acceptor photobleaching of transiently 
expressed BMPRIa-YFP and BMPRII-CFP. Normalized fluorescence intensity before and 
after photobleaching is plotted vs. time. (c,d) Single-molecule tracking traces and analysis of 
BMPRIa and BMPRIb receptor mobility on cell surface. C2C12 cells expressing respective 
HA-tagged receptors were QD-labeled via tag-specific antibodies and subjected to the 
microscopy followed by mobility analysis. Representative movement trajectories of individual 
receptor molecules demonstrate the confinement of receptor mobility to a certain area. The 
scale bar represents 100 nm. (e) SPT-based mobility analysis of BMPRII. Cells expressing 
HA-tagged receptors were labeled, imaged and analysed analogous to Fig. 1c,d. 
Representative movement trajectories of BMPRII are shown. The scale bar represents 100 
nm. (f) Average motion of receptors was determined by mean square displacement (MSD) 
analysis. MSD for each receptor type was plotted vs. time lag (tlag) and the resulting functions 
fitted to mathematical models of confined and free diffusion. Data points from 5 independent 
experiments for each receptor type were pooled. 
 
 
2.2.2. Effect of ligand application on the lateral mobility of BMP receptors 
Impact of ligand application on BMP receptor lateral mobility was measured as 
the BMP stimulation was previously shown to augment heteromeric BMPRI/BMPRII 
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complex formation (9). After BMP-2 addition FRAP analysis indicated decreased 
BMPRII mobile fraction to the level of BMPRIa what signifies that receptors get 
immobilized within minutes after ligand stimulation (Figure 2a). FRET studies were 
conducted to verify whether assembling with BMPRIa could be responsible for the 
immobilization of BMPRII. After BMP-2 application FRET increase of 10% to 20% was 
observed implying the existance of ligand dependent BMPRIa/BMPRII complexes 
(Figure 2b).  
Moreover, individual BMP receptors were monitored on living cells up to 30 min 
after BMP-2 (Figure 2c-e) or GDF-5 addition with the single-molecule microscopy 
technique. The mobility of BMPRIa and BMPRIb endured confined (Figure 2c,d,f) of a 
slightly smaller confinement size upon ligand stimulation than the one previously 
observed in ligand absence (compare MSD analysis in Figure 1f and 2f). Interestingly, 
BMPRII mobility altered drastically approximately 5 min after BMP-2 stimulation and 
displayed one population of solely confined motion with the  similar to BMPRI diffusion 
coefficient of 0.004 µm2/s and confinement size of 100 to 200 nm (Figure 2e,f). This 
mobility abating can be correlated with the formation of BMP-induced signaling 
complexes (BISCs) (10).  
To examine ligand impact on the differences in distribution of endogenous 
BMPRII cell surface biotinylation was combined with isolation of detergent-resistant 
membranes (DRMs) by sucrose gradient fractionation. Co-fractionation of the respective 
molecule with DRM-markers (e.g. Caveolin1) is the sign of its association with 
membrane microdomains. Prior to ligand addition endogenous BMPRII was present in 
both DRM- and non-DRM fractions at the cell surface and shifted to DRM fractions 
already 5 min after BMP-2 stimulation (Figure 2g,h). This suits the mobility data of 
BMPRII showing decrease of its  motion upon ligand stimulation (Figure 1a,e,f and 2). 
To further examine motionless of BMPRII in the contex of the heteromeric complex 
formation FRET and single-molecule studies with a BMPRII intracellular truncation 
mutant (BMPRII-TC1) lacking the ability to build preformed complexes with BMPRI 
(10) were performed. No FRET before ligand addition and only a 10% FRET increase 
upon BMP-2 ligand stimulation were noticed. In single-molecule analyses, the BMPRII-
TC1 had solely a freely diffusing population (D = 0.02 to 0.05 µm2/s). 
Furthermore, ligand application only slighly induced the confinement and 
immobilization of this receptor on the membrane giving values similar to arleady 
reported on HEK293 cells (17) indicating immobility correlation to oligomerization. 
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Figure 2. Lateral mobility of BMPRII is reduced upon ligand stimulation.  
(a) FRAP analysis of BMPRIa and BMPRII lateral diffusion upon BMP-2 stimulation. BMPRIa-
YFP and BMPRII-CFP constructs were transiently expressed and imaged as in Figure 1a. 
Normalized fluorescence intensity before and after photo-bleaching upon stimulation with 
BMP-2 is plotted vs. time. Percentage of recovery for both receptors is shown in the 
histogram. The reduced recovery rate of BMPRII reflects the increased amount of 
immobilized BMPRII on cell surface. 
(b) Time resolved FRET on individual cells expressing BMPRIa-YFP and BMPRII-CFP 
constructs indicated an increase of FRET after ligand.  
(c-e) SPT traces of BMPRIa, BMPRIb and BMPRIILF after 5 min BMP-2 stimulation. C2C12 
cells expressing the respective HA-tagged receptor were starved, QD-labeled and imaged 
upon BMP-2 stimulation as described for the same cells in Figure 1c. Representative 
trajectories of BMPRIa, BMPRIb and BMPRII LF show a comparable confined mobility for all 
receptors after ligand stimulation. Scale bar represents 100 nm.  
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(f) Analysis of BMPRI and BMPRII MSD vs. time shows a comparable average mobility for 
both receptor types after BMP-2 stimulation. Data points from five independent experiments 
were pooled. 
(g,h) Enhanced DRM-association of endogenous BMPRII upon ligand stimulation as 
assessed by co-fractionation with the DRM-marker Caveolin1. C2C12 cells were starved and 
stimulated with BMP-2 for 5 min. After cell surface biotinylation cells were used for sucrose 
gradient fractionation and subsequent streptavidin precipitation of biotinylated proteins. 
Precipitates were subjected to Western blot analysis. Quantification of Western blot analysis 
demonstrates the increased proportion of BMPRII in DRM-fractions after BMP-2 addition. 
 
 
2.2.3. Modulating lateral mobility of BMPRI 
BMPRIb was shown to have a strong biochemical association with cholesterol-
rich membrane microdomains (11). Therefore, in this study experiments of cholesterol 
depletion by short treatments with methyl-β-cyclodextrin (MβCD) were performed to 
better understand the effect of cholesterol-rich microdomains on the confinement of 
BMPRIb motion. Already 5 min after application MβCD caused a gradual increase up to 
180 nm in the confinement size of individual BMPRIb receptors (Figure 3a,b). After 60 
min BMPRIb showed fully free diffusion (Figure 3c,d). As control for plasma membrane 
integrity under cholesterol depleting conditions the mobility of an independent 
transmembrane receptor was analysed under MβCD treatment. For this the transferrin 
receptor (TfR), a known non-DRM protein, was subjected to single-molecule analysis. 
Mobility pattern of TfR did not change under these conditions implying that the 
membrane integrity was not affected under MβCD treatment. 
Furthermore, the role of caveolae - a subpopulation of DRMs containing 
Caveolin1 – was studied for BMPRIb mobility. Caveolae were previously shown to 
influence BMP signaling (11,19). Single-molecule analysis of siRNA-mediated 
knockdown of Caveolin1, which was performed in C2C12 cells stably expressing HA-
tagged BMPRIb (C2C12-BMPRIb wt) and verified by Western Blotting prior to the 
imaging, displayed free diffusion-like motion of BMPRIb (Figure 3e,f). These data 
provide compelling evidence that localization of BMPRIb in cholesterol-rich membrane 
microdomains and specifically in caveolae is necessary to maintain the confinement of 
BMPRIb mobility. 
Not only the chemical composition of membrane microdomains, but also 
interactions between membrane microdomains and cytoskeleton have been described 
previously (20,21,22). Obviously, any attachement to the cytoskeleton could be the factor 
hindering mobility of the BMPRIb receptors (23). That gave the reason to scrutinize the 
involvement of the microtubule network in the motionless of BMPRIb. Microtubule 
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disruption was performed by short term nocodazole treatment (up to 90 min) before 
imaging C2C12-BMPRIb wt cells with single-molecule microscopy. BMPRIb receptor 
mobility has been greatly boosted after disruption of microtubules (Figure 3g-j) indicating 
that the confinement of BMPRIb is based not only on receptor localization in membrane 
microdomains but also on cytoskeletal interactions. 
 
 
Figure 3a-f. BMPRIb confinement requires both specialized membrane domains and 
cytoskeletal components. 
(a) Short term effects of cholesterol depletion by MβCD on BMPRIb mobility as assessed by 
single-molecule microscopy. C2C12 cells expressing HA-tagged BMPRIb wt (C2C12-BMPRIb 
wt) were starved, QD-labeled and imaged in a time series 0-30 min after application of MβCD. 
Trajectories and respective MSD graphs of a single representative receptor before, 5 min and 
10 min after MβCD application demonstrate gradual mobility increase over time. Scale bar 
represents 100 nm.  
(b) MSD analysis demonstrates an MβCD-induced increase of average BMPRIb mobility of 5 
independent experiments starting at 5 min treatment duration.  
(c,d) Representative trajectories (c) and MSD analysis (d) of BMPRIb mobility after 60 min 
MβCD pretreatment show long traces and free diffusion-like motion. Scale bar represents 100 
nm.  
(e,f) Role of Caveolin1 scaffolds for BMPRIb mobility as assessed by single-molecule 
microscopy. C2C12-BMPRIb wt cells were subjected to transient shRNA-mediated Caveolin1 
knockdown. Single-molecule microscopy and analysis of BMPRIb mobility were performed as 
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described earlier. Representative trajectories (e) and MSD analysis (f) demonstrate increased 
BMPRIb lateral mobility under Caveolin1 knockdown. Scale bar represents 100 nm.  
 
 
Figure 3g-j BMPRIb confinement requires both specialized membrane domains and 
cytoskeletal components. 
(g-j) Role of cytoskeleton for BMPRIb mobility as assessed by single-molecule microscopy. 
C2C12-BMPRIb wt cells were treated with nocodazole 0, 10, 20, 40 min (g and h) and for 90 
min (i and j) to induce microtubule disruption before QD-labeling and imaging (as described). 
Representative trajectories (g and i) and MSD analysis (h and j) of BMPRIb mobility under 
these conditions show increased BMPRIb mobility upon cytoskeletal perturbation. Scale bar 
represents 100 nm.  
 
 
2.2.4. Structural elements mediating the confined mobility of BMPRIb 
To determin which of domains causes BMPRIb immobility mutagenesis of the 
extracellular membrane-proximal region (L3 loop) (24), the transmembrane (TM) and 
intracellular domains were performed (Figure 4a). Thereby some of BMPRIb mutations 
in the transmembrane region (TM2, TM5 and PKT) were recognized to cause lower co-
fractionation of the receptor with the DRM marker Caveolin1 (Figure 4b,c). This 
indicates that the transmembrane region is essential for the placement of BMPRIb within 
cholesterol-rich membrane microdomains.  
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Single-molecule microscopy was utilized to characterize HA-tagged BMPRIb 
mutans (C2C12-TM2, C2C12-TM5 and C2C12-PKT) respectively expressed in stable 
C2C12 cell lines. A substitution of three amino acids to alanine in the second turn of the 
transmembrane α-helix (PKT mutation) resulted in a fivefold increase of the BMPRIb 
confinement (Figure 4h,i). Lateral mobility of receptors get even greater when four 
successive point mutations in the same transmembrane region (TM2 mutation) were 
present (Figure 4d,e). However, the pattern of BMPRIb-TM2 motion remained confined 
but with the increased to tenfold than of BMPRIb wt confinement. Contrasting mobility 
of great and free diffusion-like motion displayed point mutations in the helix turn closest 
to the intracellular compartment (TM5 mutation) (Figure 4f,g). 
Behavior of receptor mutations was studied as well upon BMP-2 and GDF-5 
stimulation. Ligand application did not cause any significant changes to receptor mobility 
pattern. 5 min after ligand stimulation the confinement size of BMPRIb-TM2 got 
decreased by 38% but threefold increased in case of BMPRIb-PKT. 
Taken together, gathered data clearly show that the transmembrane domain is 
one of the crucial factors in confining lateral mobility of BMPRIb. 
 
Figure 4a-c. Structural components mediating the confined mobility of BMPRIb. 
(a) Mutagenesis approach for identification of structural elements responsible for the 
immobility of BMPRIb. Point mutations, a poly-alanine scan of the transmembrane domain 
and intracellular truncations of BMPRIb were generated by targeted mutagenesis. The wild 
type sequence of transmembrane domain is depicted in black, the mutated amino acids in 
red.  
(b,c) Reduced DRM-association of BMPRIb transmembrane domain (TM) mutants as 
assessed by co-fractionation of receptor with Caveolin1. C2C12-TM2, -TM5 and -PKT cells 
were used for sucrose gradient fractionation and fractions were subjected to Western blot 
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analysis (b). The histogram (c) depicts the percentage of receptor present in DRM-fractions 
obtained by quantification of the Western blot analysis. 
 
 
Figure 4d-i. Structural components mediating the confined mobility of BMPRIb. 
(d-i) Mutations of transmembrane domain increase lateral mobility of BMPRIb. C2C12-TM2, -
TM5 and -PKT cells were used for antibody-mediated QD-labeling of receptor and subjected 
to single-molecule microscopy. Representative trajectories and MSD analysis show a strong 
increase either in confinement size for the PKT (h) or in lateral mobility for TM2 (d) and TM5  
(f) in comparison to BMPRIb wt. For MSD analysis data points from five independent 
experiments were pooled. Scale bar represents 100 nm.  
 
 
2.2.5. Effects of BMPRIb mobility on SMAD-signaling 
BMP receptors transduce signals by triggering SMAD- and non-SMAD-signaling 
cascades upon ligand stimulation (1). In this study, the influence of BMPRIb increased 
mobility on signal transduction was investigated.  
SMAD-signaling that is activated through BMPRI was examined by Western blot 
analysis of C-terminal SMAD1/5/8 phosphorylation. Additionally to BMP-2 cells were 
stimulated with GDF-5 to elicit a clear response of BMPRIb and avoid confusing with 
endogenous BMPRIa. Ligand-induced activation of SMAD-signaling did not differ in 
C2C12-TM2, -TM5 and -PKT cells when compared to C2C12-BMPRIb wt cells (Figure 
5a,b upper panels). Moreover, a BMP-responsive luciferase reporter gene assay displayed 
no interference with SMAD-dependent transcriptional activation (Figure 5c). 
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Figure 5. Effects of enhanced BMPRIb mobility on signaling.  
(a,b) Western blot analysis of Smad1/5/8, p38 and Akt activation in C2C12-BMPRIb wt, -TM2, 
-TM5 and -PKT cells. Cells were stimulated with BMP-2, GDF-5 or pure PBS for 30-60 min. 
Cell lysates were subjected to Western blot analysis of respective phosphorylated proteins. 
GAPDH was used as loading control. Quantification of Western blot (b) depicts relative 
intensity of phospho-specific signals normalized to respective GAPDH.  
(c) Expression analysis of osteoblastic differentiation markers in C2C12-BMPRIb wt or mutant 
cells. C2C12-BMPRIb wt, -TM2, -TM5 and -PKT cells were starved, stimulated with GDF-5 for 
12 h or 48 h and used for RNA isolation. Quantitative RT-PCR was performed to analyze 
gene expression of Runx2, ALP, Osterix and OCN. Gene expression was normalized to 
HPRT expression and plotted as mean normalized values (MNE). 
(d) Analysis of Smad-mediated transcriptional activation by BMP-responsive reporter gene 
assay. Cells were transfected with BMP-responsive and constitutive active luciferase 
constructs, starved and stimulated with GDF-5 for 6 h. Luciferase activity was measured in 
cell lysates. Quantification shows GDF-5-induced luciferase activity normalized to constitutive 
luciferase activity. 
(e) Alkaline phosphatase (ALP) activity assay. C2C12 cells-BMPRIb wt, -TM2, -TM5 and -
PKT cells were starved and stimulated with various concentrations of GDF-5 for 72 h. ALP 
production indicative for osteoblastic differentiation was assessed by a colorimetric assay of 
enzymatic activity of ALP. 
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2.2.6. Effects of BMPRIb mobility on non-SMAD-signaling 
Western blot analysis was used to study the capacity of BMPRIb-TM mutants to 
activate p38 MAPK and PI3K/Akt pathways. C2C12-TM2, -TM5 and -PKT cells 
showed no GDF-5 induced activation of p38 and Akt (Figure 5a,b middle and lower 
panels), and only slight activation upon stimulation with BMP-2 that is elicited through 
both BMPRIb and endogenous BMPRIa. 
The transcriptional effects of  non-SMAD-signaling were estimated by expression 
analysis of BMP target genes Runx2, Osterix (Osx), Osteocalcin (OCN) and Alkaline 
Phosphatase (ALP). Expression of the early and mainly Smad-dependent osteoblastic 
marker Runx2 was unimpaired upon GDF-5 induction (Figure 5d, upper panel), however 
ALP expression, which necessitates both SMAD- and non-SMAD-signaling and is a later 
marker of osteogenesis, showed sharp decrease in C2C12-TM2, -TM5 and -PKT cells 
(Figure 5d, lower panel). Moreover,  upon ligand stimulation expression of Osx and OCN 
was compromised solely in the C2C12-TM5 cell line (Figure 5d) with TM5 being the 
mutation of the highsest impact on BMPRIb lateral mobility. 
The enzymatic activity of ALP was examined in cells expressing particular 
transmembrane mutants to estimate osteoblastic differentiation. The ALP activity assay 
revealed GDF-5 induced ALP-production in C2C12-TM2, -TM5 and -PKT cells to be 
significantly reduced in comparison to C2C12-BMPRIb wt (Figure 5e). However, BMP-2 
induced ALP-production did not differ in these cells implying no signaling interference 
between the mutated BMPRIb and endogenous BMPRIa. 
Taken together, obtained data have clearly shown that restricted lateral mobility 
of BMPRIb is essential for efficient non-SMAD-signaling and osteoblastic differentiation 
of C2C12 cells but not necessary for canonical SMAD-signaling. 
 
 
2.2.7. Effect of BMPRIb lateral mobility on receptor internalization 
The internalization of BMPRIb-TM mutants was measured in the ligand absence 
and upon ligand stimulation. FACS-based internalization studies (25) were conducted in 
HEK293T cells transiently expressing equal amounts of HA-tagged BMPRIb wt or 
respective mutants to examine basal endocytosis. The time-dependent decrease of 
fluorescently stained receptors from the surface was measured by FACS. The 
internalization of all BMPRIb-TM mutants was observed at similar to BMPRIb wt rates 
(Figure 6a). 
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Estimation of the internalization was proceeded with the usage of single-
molecule microscopy. Individual QD-labeled receptors were tracked before and after 
ligand stimulation in C2C12 cells stably expressing the respective receptors (Figure 6d-g). 
Initially, BMP-2 application caused BMPRIb-TM mutants to internalize with varied 
tempo (t = 2-15 min) than BMPRIb wt, however after 30 minutes of ligand presence 
nearly all receptors vanished (Figure 6d-g), hence endocytosis is not impaired under 
increased lateral mobility of BMPRIb. 
 
Figure 6a. Increased lateral mobility of receptor does not impair receptor endocytosis.  
(a) FACS-based analysis of BMPRIb internalization. HA-tagged BMPRIb wt or mutant 
receptors transiently expressed in HEK293T were fluorescently labeled and the decrease of 
surface fluorescence assessed by FACS-measurements. The line plot depicts the time-
dependent decrease of mean fluorescence indicative of receptor internalization. 
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Figure 6b-g. Increased lateral mobility of receptor does not impair receptor 
endocytosis.  
(b-g) Single-molecule analysis of receptor internalization. HA-tagged receptors and receptor 
mutants stably expressed in C2C12 cells were QD-labeled, ligand stimulated and observed 
up to 30 min until nearly all receptors internalized. The internalization of following receptor 
was analysed: BMPRIb wt (d); BMPRIb-TM mutants -TM2 (e), -TM5 (f), – PKT (g), BMPRII 
(b), BMPRII-TC1 (c). Receptor internalization is plotted as % of internalized receptors vs. time 
without ligand application (grey lines) and after stimulation (black lines). Each internalization 
profile includes data from five independent experiments. 
 
 
2.2.8. Effect of BMPRIb lateral mobility on BMPRI/BMPRII hetero-oligomerization 
Dual-colour single-molecule microscopy was utilized for analysis of 
BMPRIb/BMPRII hetero-oligomerization in living cells. C2C12-BMPRIb wt or mutant 
cells were transiently transfected with Myc-tagged BMPRII. Receptors were antibody 
labeled with quantum dots of two different colors for BMPRI and BMPRII, respectively. 
Single-molecule microscopy was applied to visualize and analyze co-localization over 
time. BMPRIb and BMPRII were observed to oscillate between longer and shorter 
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distances, several times getting close together and again separate, which indicated very 
dynamic and transient binding between the BMP receptors rather than a stable union 
(Figure 7a,b). Such behavior of receptors has been recently reported (26). 
Analysis of ligand-independent BMPRIb/BMPRII co-localization enabled to 
define a mean time of receptor unification (“complex lifetime”) to be < 0.4 s for both 
BRMPIb wt and TM-mutants. BMPRIb wt and BMPRII complex members were 
oscillating 3 to 4 times between separating from each other and re-gathering for almost 
one second. However, ligand application increased the duration of co-localization 
between BMPRIb wt and BMPRII by more than twofold and would recombine on 
average more than 10 times for a total combination time of at least five seconds, 
suggesting a stabilization of BMPRI/BMPRII complex upon ligand binding (Figure 7c). 
In contrast, BMPRIb-TM mutants neither displayed prolonged co-localization with 
BMPRII upon ligand stimulation nor did they on-average recombine more than twice. 
Therefore, increased lateral mobility of BMPRIb evidently impairs the stabilization of 
BMPRI/BMPRII complexes upon ligand binding but does not hinder ligand-
independent interaction with BMPRII. 
 
 
Taken together, single-molecule study revealed a confined lateral mobility of 
BMPRIa and BMPRIb and two populations, mobile and immobile, of BMPRII. It was 
presented that BMPRII mobility is reduced upon ligand stimulation, what most probably 
mirrors a complex formation with BMPRI. Furthermore, the confinement of BMPRIb 
depends on transmembrane region, necessitates cholesterol-rich membrane regions and 
cytoskeletal components. Finally, we demonstrate that the confined mobility of BMPRIb 
is essential for i) ligand-induced stabilization of BMPRIb/BMPRII complex, ii) 
navigation of non-SMAD responses and iii) subsequent osteoblastic differentiation. 
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Figure 7. Mobility of BMPRI important for stability of BMPRI/BMPRII hetero-oligomers. 
(a) Colocalization dynamics of an individual QD585-labeled HA-BMPRIb receptor (green) and 
an individual QD655-labeled Myc-BMPRIILF receptor (red) before BMP-2 addition on the 
surface of a C2C12 cell over time. Colocalization is presented by a merged yellow colour. The 
receptors are shown to come together and dissociate twice.  
(b) Time-resolved separation distance analysis of the same receptors from a). A threshold 
distance of 400 nm (dotted line) was applied to determine the minimal colocalization length to 
reveal the typical behavior that the receptors separate, recombine and to determine the 
colocalization and separation times.  
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(c) Time of colocalization between BMPBRII and BMPRIb wt or particular TM mutants 
presented before and 5 min after BMP-2 addition. Diagram includes data from five 
independent experiments and equal number of potential complex pairs. BMP-2 stimulation 
amplifies the time of colocalization between BMPRII and BMPRIb wt by twofold, whereas 
between BMPRII and BMPRIb-TM mutants no extention in colocalization time was observed . 
(d-g) Single-molecule quantification of the internalization of BMPRII transiently co-expressed 
in C2C12 cells with stable expression of HA-BMPRIb wt or HA-BMPRIb-TM mutants C2C12 
cells. ACP-tagged BMPRII was transiently transfected in stable C2C12 cell lines, labeled with 
QD655 and studied up to 30 min after BMP-2 addition on single-molecule microscope. Each 
internalization profile includes data from five independent experiments.  
 
 
2.2.9. Discussion 
BMPs activate non-SMAD pathways including MAPKs (p38, ERK, JNK) (8,10) 
PI3K/Akt and small GTPases (Rho, Rac, Cdc42) (27) which are crucial for osteoblastic 
differentiation (28,29) and other cellular responses to BMP (30). However, the factors 
determining balance between SMAD- and non-SMAD-signaling remain unclear. 
In this study the conclusive postulate has been made that receptor lateral mobility 
navigates through SMAD versus non-SMAD signaling during differentiation. The 
confinement of BMPRI has been shown as essential factor for activation of p38 and Akt 
but not of canonical SMAD-signaling. 
It was previously reported that disruption of membrane microdomains by 
cholesterol depletion interferes with p38 activation and osteoblastic differentiation of 
C2C12 cells (11). Here, we demonstrate that mutations in the transmembrane domain of 
BMPRIb mimic this chemical treatment in respect to the lateral mobility of receptor and 
the selective reduction of non-SMAD responses. 
We also studied the role of a membrane-proximal, negatively charged extracellular loop 
(L3 loop) which could target the receptor to microdomains that are enriched in positively 
charged glycosphingolipids. Only minor effects of the L3 loop mutations on the lateral 
mobility and no effects on the signaling properties of BMPRIb were noticed. This 
implies that the transmembrane region is the key mediator of the microdomain 
association and hence mobility of BMPRIb.  
Furthermore, the increased lateral mobility of receptor was shown not to impair 
constitutive or ligand-induced receptor internalization. It also does not affect formation 
of heteromeric BMPRI/BMPRII complexes. Thus the BMPRI/BMPRII complex is 
formed and enough stable to allow the transphosphorylation of BMPRI. This is the 
reason why enhanced motion does not impair SMAD-signaling. On the other hand, 
efficient induction of p38 and JNK pathways requires the formation and activation of 
XIAP-TAB-TAK complex, which was shown to have interactions with both receptors 
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(8). Possibly, this process necessitates a greater stability of the heteromeric receptor 
complex which can be observed for BMPRIb wt upon ligand binding (as shown by dual 
colour single-molecule microscopy experiments) but can not be established if lateral 
mobility of BMPRI is increased e.g. by mutation. 
To examin association of the BMPRII immobility with heteromeric complex 
formation, single-molecule experiments with a BMPRII intracellular truncation mutant 
(BMPRII-TC1) were conducted. BMPRII-TC1 was previously described as a receptor 
mutant lacking the ability to build preformed complexes with BMPRI (10). In single-
molecule microscopy and mobility analysis this mutant had a homogeneous freely 
diffusing population with very short immobilization after BMP-2 stimulation. This might 
imply that the immobility of BMPRII mirrors its hetero-oligomerization with BMPRI. 
BMP type I receptors have been shown here to associate with DRMs, whereas 
BMP type II receptor is found in both DRM- and non-DRM fractions and is shifted to 
DRM-fractions upon ligand application. This differs from previous results in which 
neither BMPRIa nor BMPRII were associated with DRMs unless stimulated with a ligand 
(12). However, that studies were conducted in cells that already underwent chondrocytic 
differentiation. Possibly, differentiation abolishes the DRM association of receptors to 
rminimize specific signaling pathways that require DRM association. Our data imply that 
the localization of BMP type I receptor is required for BMP-induced MAPK activation 
and osteogenic differentiation, thus the DRM-association of receptors might be a general 
mechanism to modulate the ratio between different responses during differentiation.  
Moreover, live cell imaging including single-molecule microscopy and FRAP 
clearly showed greaterl mobility for BMPRII that 5-10 min upon ligand stimulation is 
decreased to the level of BMPRI and gets a confined profile for the whole existing 
population of receptors. The application of high temporal resolution and surface labeling 
in biochemical experiments enabled to exclude endocytotic events and to focus on 
immediate-early processes on the plasma membrane. 
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2.3. Materials and methods 
 
 
 
2.3.1. Constructs, antibodies and reagents 
The DNA fragments encoding fluorescent proteins (pEYFP and pECFP (Clontech)) and 
Acetyl Carrier Protiens (ACP) were PCR amplified and inserted in-frame to the N- 
terminus of the DNA sequences encoding for the BMP receptors type Ia, Ib, II and II-
TC1, including linker regions (17). All fusion constructs were ligated into the pcDNA3 
expression vector (Invitrogen) for transient expression in mammalian cells. The 
expression of BMPRII-TC1 was tested in transfected HEK, Cos-1 cells and C2C12 cells. 
Antibodies were obtained from following companies (dilution is stated in the brackets): 
α-HA tag (clone HA-7) (1:1000 for Western blot, 1: 400 for immunofluorescence studies) 
from Sigma-Aldrich; α-BMPRII (1:500) and α-Caveolin1 (1:1000) from Santa Cruz 
Biotechnology; α-transferrin receptor (1:1000), α-phosphorylated SMAD1/5/8 (1:1000), 
α-phosphorylated SAPK/JNK Thr 183/Tyr185, α-phosphorylated Akt Thr308 (1:1000), 
anti-Myc tag (1:1000 for Western blot, 1: 400 for immunofluorescence studies) and α-
GAPDH (1:1000) from Cell Signaling Technology, α-phosphorylated p38 motif PTGPY 
(1:2000) from Promega. 
Methyl-β-cyclodextrin, nocodazole and polyethylenimine (PEI) were purchased from 
Sigma-Aldrich. Anti-Caveolin1 siRNA and control siRNA were purchased from Santa 
Cruz Biotechnology and transfected with the siRNA transfection reagent from Santa 
Cruz Biotechnology. 
 
2.3.2. Cell culture and transfection 
C2C12 and HEK293T cells (both purchased from American Type Culture Collection) 
were cultivated in Dulbecco’s modified Eagle’s culture medium (Biochrom, Germany) 
supplemented with 10% v/v fetal bovine serum (Biochrom), 2 mM L-Glutamin (PAA), 
100 U/ml Penicillin (PAA) and 100 mg/ml Streptomycin (PAA) at 37oC/10% CO2. For 
transient transfection LipofectamineTM 2000 (Invitrogen) was used according to 
manufacturer’s instructions. Cells were seeded out on plates (Sarstedt) or glass coverslips 
(24mm, class 1, Hartenstein GmbH) and used for assays or imaging 20 h to 48 h post 
transfection. For transient transfection of HEK293T cells polyethylenimine (PEI) 
(Sigma-Aldrich) ) or Effectene (Qiagen, Hilden, Germany) was used as described earlier. 
Stable C2C12 cell lines were established by retroviral transduction of GatewayR-based 
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(Invitrogen) HA-tagged BMPRIb wt or respective mutant constructs followed by 500 
µg/ml Hygromycin B  selection and FACS sorting. 
  
2.3.3. Separation of detergent-resistant membrane microdomains (DRMs) 
Isolation of DRMs was performed as described (11). In short, C2C12 cells were lysed 
with buffer containing 20 mM (3-[(3-cholamidopropyl)-dimethylammonio]-1-
propanesulfonate) (CHAPS), 25 mM Tris-HCl pH 7.4, 150 mM NaCl, 3 mM EDTA, 
protease and phosphatase inhibitors in according concentrations for 30 min at 4° C, 
homogenized with a Potter apparatus and cleared of cell debris by centrifugation. The 
lysate was adjusted to a concentration of 40% OptiPrepTM (Axis-Shield, Scotland) and 
layered with a discontinuous OptiPrep gradient (30%, 5%). Following ultracentrifugation 
(20 h, 39000 rpm, 4°C, SW40Ti Beckman rotor) the gradient was fractionated by 
pipetting 10 - 11 fractions of equal volume from the top, which were denaturated and 
analysed by SDS-PAGE and Western blot. 
 
2.3.4. Cell surface biotinylation 
Cell surface biotinylation was performed by incubating adherent cells with 0,5 mg/ml 
EZ-LinkTM Sulfo-NHS-LC-Biotin in PBS (Pierce) for 1h at 4°C. Subsequently cells were 
washed for 10 min with 50 mM Tris pH 8,0 to quench Biotin and processed for DRM 
separation as described above. For precipitation of biotinylated proteins after sucrose 
gradient ultracentrifugation fractions were treated as described (34). In short, fractions 
were adjusted to equal sucrose concentration and 1% TritonX. Next they were incubated 
at 37° C for 15 min and cleared of insoluble particles by centrifugation. Then biotinylated 
proteins were isolated by incubation and precipation with Streptavidin-SepharoseTM 
beads (GE Healthcare), denaturated and subjected to Western blot analysis. 
 
2.3.5. Dual luciferase reporter gene assay 
C2C12 cells (5*103 per well of 96-well plate) were transfected with 40 ng BMP response 
element (BRE)-fused firefly luciferase construct (p(BRE)4-luc) (32) and 30 ng Renilla 
luciferase construct (pRLTK). 20 h post transfection cells were serum starved and 
subsequently stimulated with 1-10 nM BMP-2 or GDF-5. Cell lysis and luciferase 
measurements were carried out according to manufacturer’s instructions (Dual-
Luciferase Reporter Assay System; Promega). Luciferase activity was measured by 
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Mithras plate luminometer (Berthold Technologies, Germany). All measurements were 
conducted in triplicates. 
 
2.3.6. Alkaline phosphatase activity assay 
C2C12 cells (1,5 *104 per well of 96-well plate) were grown for 20 h in normal growth 
medium, starved for 2 h in serum-reduced medium (2% FCS) and treated for 72 h with 
various concentrations of BMP-2 or GDF-5 (1-20 nM) in serum-reduced medium. Cells 
were lysed and alkaline phosphatase activity was determined as absorption at 405 nm as 
described (33Katagiri, Yamaguchi et al. 1994). 
 
2.3.7. Western Blot analysis of SMAD- and non-SMAD signaling 
C2C12 cells (1,5*105 per well of 6-well plate) were grown for 24 h in normal growth 
medium, starved in serum-reduced medium and stimulated with 1-10 nM BMP-2 or 
GDF-5 for 15 min – 60 min. Stimulation was stopped by cell lysis. As a control for each 
time point stimulation with pure PBS occurred for the same duration as ligand stimulated 
samples. After denaturation samples were analysed by SDS-PAGE and Western blotting. 
Western blots were probed with phospho-specific antibodies to detect activation of 
various players of SMAD- and non-SMAD pathways. 
 
2.3.8. Quantitative Reverse Transcription – PCR 
C2C12 cells (3*105 per well of 6-well plate) were grown for 24 h in normal growth 
medium, starved for 2-5 h in serum-reduced medium and stimulated for 12 h, 24 h or 48 
h with 10 nM BMP-2 or GDF-5. Total RNA was extracted using NucleoSpinR RNA II 
Kit (Macherey-Nagel, Dueren, Germany) according to manufacturer's instructions. 
cDNA was synthesized from 1 µg RNA and used in SYBR Green quantitative real-time 
PCR in 1:8 dilutions. The amount of following transcripts: Runx2, Osterix, Alkaline 
Phosphatae (ALP) and Osteocalcin (OCN), was determined relative to the housekeeping 
gene hypoxanthine-phosphoribosyltransferase (HPRT). For each gene real-time PCR 
reactions from BMPRIb wt versus mutant receptor expressing samples under the 
respective stimulated and unstimulated conditions were performed. All measurements 
were done in triplicates (StepOnePlus instrument from Applied Biosystems) and C(T) 
values were determined using StepOne Software v2.2. Mean normalized expression 
(MNE) and the corresponding standard error (SE_MNE) were calculated according to 
(Simon, 2003 #30). 
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2.3.9.Fluorescence Tagging - Quantum Dot Labeling of ACP 
Labeling was performed by incubating the cells on the cover slips for 15-20 min at 37oC 
in DMEM (270 µl) with 1% Bovine Serum Albumin (BSA, Sigma-Aldrich); 1.5 µM 
6xHis-PPTase and 0.3 nM CdSe/ZnS Quantum Dot – CoA molecules prepared with the 
655 QDot Antibody Conjugation Kit (Molecular Probes, Invitrogen). Before 
measurements samples were washed three times with 300 µl DMEM. Experiments were 
conducted on cells in 250 µl DMEM (17). 
 
2.3.10. Quantum Dot Antibody Labelling of HA- and Myc- tagged Receptors 
The primary α-HA (clone H7, Sigma, Taufkirchen, Germany) or α-Myc (Cell Signaling) 
antibodies 0,6 µl and 2 µl at 0.1 mg/ml were incubated on the transfected cells with in 
100 µl growing media at 37° C for 10 minutes then washed three times with 300 µl 
DMEM containing 10% FCS. To avoid non-specific binding, cells were incubated with 
full media plus 5% goat serum (Sigma-Aldrich) 5 min at 37° C, then again triple washing 
step occurred. Quantum Dots (QD-655 and QD-585) conjugated with specific secondary 
antibodies to α-mouse and α-rabbit.  (Invitrogen, USA), 0.35 µl in 200 µl growing media, 
were added to the cells following the primary antibody addition procedure for 25-30 
minutes at room temperature and was washed three to five times with Phenol Red-free 
DMEM.  
 
2.3.11. Cholesterol extraction by MβCD treatment 
Cholesterol depletion was done by incubation the cells in DMEM supplemented for a 
total concentration of 5 mM methyl-β-cyclodextrin (MβCD, Fluka) (or methyl-β-
cyclodextrin, MβCD, Sigma-Aldrich Chemie, Steinheim, Germany) either in an incubator 
for 1 h at 37°C with 10 % CO2  (95% humidity) with subsequent washing with full media 
or with application directly on the microscope. Data after these procedures were 
recorded over a period of one to two hours. 
 
2.3.12. Microtubules Destablization 
Polimerization of microtubules was interfered by: incubating the cells for 1 h at 37°C 
with 10 % CO2 (95% humidity) in DMEM supplemented with 5 µM nocodazole that was 
kept another 30 min on the cells during staining and imaging (i.e. 1,5h in total.); or by 
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direct addition of 5 µM nocodazole to the imaged sample. Time points measured after 
the nocodazole treatment: 0, 2, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55 and 60 minutes.  
 
2.3.13. BMP addition 
In most cases, BMP-2 (Sigma-Aldrich, USA) was used as a cytokine ligand for BMPRI 
and BMPRII receptors, with final concentration of 0.5 nM, 1 nM, 2 nM, 20 nM, and 40 
nM. The ligand addition occurred either through an injection system (InjectMan, 
Eppendorf, Germany) or perfusion system (either home-built or Manufacturer, Country).  
In some cases for comparison, after recording the data on unstimulated cells 2 µl of 20 
µM BMP-2 (provided as a kind gift from Prof. Walter Sebald, Physiological Chemistry, 
Würzburg, Germany) solution were added directly to the media or buffer solution of the 
sample to get the final reported concentration of the ligand. After allowing the samples 
to diffuse throughout the sample, recording was continued.  
 
2.3.14. Confocal microscopy 
HEK293T, COS-1 or C2C12 cells were grown to 50% confluence on 24 mm glass cover 
slips, transiently transfected, and incubated in complete DMEM medium for 24 h. After 
this, cells were perfused with PBS. Cells were analyzed before or after treatment with 20 
nM BMP-2. All live cell imaging was performed at room temprature. The fluorescence 
images were recorded on a Leica SP5 confocal microscope with a 63× NA 1.4 objective. 
The fluorescence emission resulted from excitation with 458 (for CFP) and 514 (for 
YFP) nm laser lines from an argon ion laser (Coherent Inova, I-308) from the modified 
Zeiss LSM-410 or Lasos (DMI 600B, Germany) with the Leica SP5 LSM confocal with 
internal spectral parameter settings of 458 for CFP and 514 nm for YFP. The 
fluorescence was detected with either optical filter sets from the microscope 
manufacturer using a 475–495 band pass filter for CFP and a 530–585 band pass filter 
for YFP or with a 490–500 nm spectral band width setting for CFP and a 520–590 nm 
spectral band width setting for YFP on the Leica SP5. For imaging of quantum dots on 
the confocal microscope either a D655/40 emission filter (Chroma, USA) in the Zeiss 
LSM-410 or a spectral window of 635-675 in the Leica SP5 was used.   
 
2.3.15. FRET microscopy measurements 
 In this study, a fluorescence microscope was used to perform FRET 
measurements (resf-). We quantified the FRET signal by calculating excess acceptor 
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emission using FRET ratios from defined regions of interest in, for example, the cell 
membrane. The setup for fluorescence resonance energy transfer between the cyan and 
yellow fluorescent proteins comprises an inverted microscope (Axiovert 200, Carl Zeiss) 
equipped with a high numerical aperture objective (Plan Apochromat 100×, 1.4 NA, Carl 
Zeiss). Samples were excited with wide-field light from a computer-driven 
monochromator Xenon lamp source (Polychrome IV, Till Photonics) at 436 ± 5 nm 
(CFP) and 480 ± 5 nm (YFP) that was connected to the microscope with an optical light 
guide and optical focusing system (Till Photonics) with the excitation light reflected by a 
dichroic beamsplitter (for CFP and FRET measurements, DCLP 460 or for YFP 
measurements, DCLP 490, Chroma) into the microscope objective. The fluorescence 
images and recordings were made by detection from a CCD camera (Coolsnap HQ, 
Photometrics) with the image on the CCD camera split spectrally in half and re-imaged 
on the CCD with a relay system with a dichroic beam splitter at 505 nm and two filtered 
split images bandpass filtered again with the a 480 ± 20 nm for CFP emission and the 
other at 535 ± 15 nm for YFP emission (Dual View, Optical Insights). FRET (including 
the individual CFP and YFP) signals and images were acquired every 1 s. 
 FRET is calculated as the ratio of the corrected YFP and CFP emission 
intensities at 535 ± 15 nm (IYFP) and 480 ± 20 nm (ICFP(436) ): IYFP/ICFP(436) upon 
excitation of CFP at 436 ± 5 nm (beam splitter DCLP 460 nm). The YFP (acceptor) 
direct excitation factor was determined with YFP transfected cells only. The YFP 
fluorescence was recorded first with 436 ± 5 nm excitation (FY,436). Next the YFP 
emission was recorded with 480 nm excitation (FY,480). The direct excitation crosstalk 
was calculated by FY,436/FY,480 and was equal to 0.06 ± 0.01. The YFP only cells did 
not show any emission intensity in the CFP emission channel with 436 ± 5 nm 
excitation. The bleed-through or spillover crosstalk of CFP (donor) into the 535-nm 
channel was determined first from cells expressing CFP with 436 ± 5 nm excitation (and 
also of pure recombinant CFP) only showed that the 535 nm channel had 56% of the 
intensity of the 480 nm channel. The FRET ratio calculation was performed in the 
following steps to ensure correct subtractions of signals for FRET(ref-) : (1) we identify 
and subtract the spillover of the CFP in the YFP channel to determine the pure YFP 
component due to FRET and direct excitation: YFPsum = IYFP(436 nm) − ICFP(436 nm) × 
0.56, (2) we identify and subtract the direct excitation component to determine the YFP 
signal due to FRET: YFPFRET (or IYFP) = YFPsum − 0.06 × YFP(480 nm), and (3) the 
FRET ratio was then calculated by the formula: FRETratio = IYFP/ICFP(436 nm). 
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 FRET data were acquired for a long time periods before ligand addition to make 
sure that both the cyan site and yellow fluorescent protein signals were stable and were 
not photobleaching. Otherwise, the measurements were discontinued and not included in 
these results. 
 To study agonist-induced changes in FRET, cells were placed in FRET-buffer or 
in DMEM (0.5% FCS) and BMP-4 (20 mM) was applied. As a negative control on the 
cell the FRET-buffer or DMEM (0.5% FCS) was applied to show that the FRET change 
was induced by BMP-4 addition but not by buffer or media. The imaging data were 
analyzed with Origin (Microcal) software. ImageJ and MetaMorph 5.0 (Universal 
Imaging) were also used in some cases. All live cell imaging was performed at room 
temperature. 
 We proved FRET by photobleaching the acceptor and then observed the donor 
dequenching (donor signal increase). The calculation of relative CFP:YFP concentrations 
for the intermolecular FRET were corrected by dividing by the brightness of the 
individual, initial CFP (ICFP(436)) and YFP (IYFP,corr) intensities: ICFP(436)/(tCFP εCFP,436 φCFP) 
and IYFP, corr/(tYFP εYFP,436 φYFP) where tCFP and tYFP are the optical transmissions for CFP 
and YFP in the respective CFP (0.35) and YFP (0.60) detection channels, εCFP,436 and 
εYFP,436 are the molar extinction coefficients of CFP (28,000 M
−1 cm−1) and YFP (7,000 
M−1 cm−1) at 436 ± 5 nm excitation, respectively, and φCFP and φYFP are the fluorescence 
quantum yields of CFP (0.36) and YFP (0.76) (refs-). 
 
2.3.16. Single-molecule microscopy 
 Our primary experimental design is a custom arrangement for wide-field single-
molecule imaging. Different versions have been described previously in detail (refs.). 
Briefly, cells adherent to glass slides were mounted onto the microscope and kept in 
phenol red free DMEM (Invitrogen) at 37° C. The single-molecule images were obtained 
with a Zeiss Axiovert 200 microscope (Carl Zeiss, Jena, Germany) with a 100× oil-
immersion objective (Plan Apochromat Oil, NA=1.4, Zeiss, Oberkochen, Germany) and 
with an objective heater with temperature controller (Bioptecs, Colorado USA and 
Visitron, Germany) to keep the cells at 37oC. The samples were illuminated for 3 to 10 
ms by an Ar+-laser (Coherent, Dieburg, Germany, and Santa Clara, CA USA) at a 
wavelength of 514 nm and by the 473 nm laser line of a diode laser (MB-473-100, CNI 
Laser, China). The control of pulse length was performed by focusing into either a fast 
mechanical shutter (nm laser, CA, USA) or into an AOTF (Acousto Optic Time 
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Frequency Modulator, AA Optic, France). A synchronization signal of the camera 
exposure was directed as a trigger to either a computer DACA board (National 
Instruments, Munich Germany or Austin TX, USA) or to a computer-programmable 
pulse generator (Hameg, Germany) to steer the pulse length. The illumination intensity 
was set from 0.35 to 0.9 kW/cm2 ±0.2 kW/cm2 (or 3 to 5 kW/cm2 ±0.2 kW/cm2 for 
fluorophores in the control experiments listed below) either via setting of the throughput 
voltage of the AOTF or from placement of neutral density filters in the beampath to 
proper attenuation. With appropriate filter combination (DCLP525, DCLP555, 
DCLP645, HQ605/75, D655/40 or HQ690/90 Chroma Technology, Rockingham, VT, 
USA; or OG550-3, Schott, Mainz, Germany) along with a peltier-cooled slow-scan CCD 
camera system (1300B, Princeton Instruments, Trenton, NJ, USA) or of the peltier-
cooled EMCCD-camera system (CascadeII 512B, Roper Scientific, USA), single-
molecules of either tetramethyl rhodamine (TRITC) (from Moleculear Probes, 
Netherlands) with a total detection efficiency of 12 % or quantum dots with emission at 
655 nm (QD655) (Invitrogen, USA) with a total detection efficiency of 14% could be 
detected. For the observation of the localization and mobility of the anchored 
fluorophores the focus was set to the apical membrane of the cell with a depth of focus 
of ~1 µm. The density of fluorescent proteins on the plasma membrane of transfected 
cells was < 1 µm-2 to permit imaging and tracking of individual fluorophores on average 
except for the cases when the membrane receptor proteins aggregated through natural 
cell signaling processes. 
 
2.3.17. Single molecule and total internal reflection (TIRF) microscopy  
 The cells were illuminated at 405 nm by a diode laser (Cube 405 nm – 50 mW, 
Coherent Laser, USA/Germany) for either CFP or QDots or a 488 nm laser for YFP or 
QDots synchronized with a CCD camera (Cascade 512B, Photometrics, USA), an 
acousto-optic tunable filter (AOTF), and an objective type total internal reflection 
microscope (AM TIRF – DMI 6000, Leica Microsystems GmbH, Wetzlar, Germany) 
with a 100x objective (PlanApo 100x NA 1.45, Leica, Wetzlar, Germany) controlled with 
LASAF software (Metamorph provided exact timing of the illumination time, intensity 
and wavelength. Single molecules were visualized using an objective type total internal 
reflection microscope (AM TIRF – DMI 6000, Leica Microsystems GmbH, Wetzlar, 
Germany) with a 100x objective (PlanApo 100x NA 1.45, Leica, Wetzlar, Germany). 
Fluorescence signals from TMR were monitored through a dichroic mirror in 
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combination with a band-pass (for 568nm, Chroma Technologies) by a CCD camera at 
30-msec intervals (Cascade 512B, Photometrics, USA).  Typically 500 readouts of a small 
region of the full array (typically 100x100 pixels, i.e.16 x 16 µm2 in the image plane, of a 
total 512 x 512 pixels) of the CCD chip was acquired to the PC.  
 
2.3.18. Fluorescence Recovery After Photobleaching (FRAP) 
 All live cell imaging was performed at 37°C. The fluorescence images were 
recorded on either a modified confocal microscope (LSM-410, Carl Zeiss, Göttingen, 
Germany and LSM Tech, Stewardstown, PA, USA) with a 100x NA 1.3 objective (Carl 
Zeiss, Goettingen, Germany) or a Leica SP5 confocal microscope (Leica, Mannheim, 
Germany) with a 63x NA 1.4 objective (Leica, Wetzlar, Germany). The fluorescence 
emission resulted from excitation with a 514 nm laser LSM-410 confocal microscope 
(Zeiss, Jena, Germany) or with the Leica SP5 LSM (Leica, Mannheim & Wetzlar, 
Germany) confocal microscope. The fluorescence was detected with  either optical filter 
sets from the microscope manufacturer using a LP530 in the modified LSM-410 confocal 
microscope (Zeiss, Göttingen, Germany) or with the Leica SP5 confocal microscope 
(Leica, Mannheim, Germany) a  530-610 nm spectral band width setting for the YFP. For 
FRAP on the LSM-410 confocal microscope, the 514 nm laser was synchronized with 
custom electronics (Lab View, National Instruments, Austin, TX, USA) and an acousto-
optic modulator (AOM, Isomet, USA) for the 514 nm line to allow light intensity to be 
adjusted on a pixel-by-pixel basis for wither imaging or photobleaching. The green 
excitation light was sent through focusing optics and the AOM and then directly into the 
microscope. 
 For FRAP experiments, all scans were 128 x 128 pixels representing a 64 x 64 µm 
area. Prebleach images were first acquired to analyze prebleach intensity.  Each image 
was scanned within 200 ms, and four images per second were acquired.  For the bleach, 
the scanner mirror range was reduced by a factor of 16 in order to zoom in to a 4 x 4 µm 
area on the surface of a cell and a simultaneous trigger was sent from the LSM to a 
Labview (National Instruments, USA) program which allowed the user to define the 
appropriate timing (delay and duration of the bleach pulse) by precisely controlling the 
voltage signals to the AOM to increase laser intensity for the time of the bleach scan, and 
then returned back to normal scanning intensity when bleach scan was finished.  
Bleaching occurs in 200 ms, and the first image was taken 200ms after the bleach was 
finished.  Then 15 images were taken every 250 ms, follwed by 20 images every 500ms, 
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10 images every 1 seconds, 10 images every 2 seconds and finally 70 images every 4 
seconds for faster diffusing samples, or 15 images were taken every 250 ms, followed by 
20 images every 500 ms, 10 images every 2 seconds, 10 images every 4 seconds and 
finally 70 images every 8 seconds for slower diffusing samples.   
 
2.3.19. FRAP Analysis 
The images were analyzed with the use of Image J (NIH, USA) and the data was 
exported to Origin (Origin Labs, USA) for analysis. Average fluorescence intensities 
within Regions of Interest (ROI) in the bleached regions were analyzed for each 
detection channel to obtain the recovery data. Corrections were made for photobleaching 
during scanning by monitoring neighboring cells and analyzing their signals.  Mobile 
fractions were calculated and the recovery was fit to the equation:  I = A1 - A2*exp(-k*t) 
where I is the average intensity, k is the rate of the exponential recovery, t is the time, A1 
is the full recovery value and A2 is the value of the drop in intensity after the bleach.  
Two component recovery analysis was also applied to data and fit to the equation:  I = 
A1 - A2*exp(-k1*t) – A3*exp(-k2*t).  Percentage of immobile fraction is calculated by 
comparing pre-bleach intensity with recovered intensities.   
 
2.3.20. Data analysis 
accodrding to the point 1.3.7. 
 
2.3.21. Mobility analysis 
accodrding to the point 1.3.8. 
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 3  
 
 
Quantum dots for single-molecule biological imaging on  
native cell membranes 
 
 
 
 
 
 
Quantum dots have lately been presented as an usuful and effective tool for the 
visualization and tracking of individual proteins on the cell surface. Usage of these 
nanoparticles and QD-labeling methods, however, still require optimization, especially to 
allow more exact calculation of the membrane protein stoichiometries in larger 
assemblies. In this study described are methods that augment the number of signals and 
the tracking times of diverse QD types. These techniques were applied to peruse 
interleukin-5 β-common chain receptor (IL-5Rβc) receptors that are endogenously 
expressed at low level on living differentiated eosinophil-like HL-60 cells. 
Gathered data reveal that examined receptors form stable and higher order 
oligomers. Higher than 10% maximization of uninterrupted trajectories of totally 
uninterrupted 1000-step trajectories displays two patterns of confined motion. 
Thereupon procedures were evolved that enable determination of stoichiometries of cell 
surface protein complexes, even at native non-transfected levels, as well as the 
observation of long trajectories to analyze their mobility. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Submitted to Nature Methods 
Zelman-Femiak M, Noskov A, Lambright G, Bhushan S, 
Lohse MJ, Harms GS 
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3.1. Introduction 
 
 
 
Receptors play a decisive role in cellular signaling events, hence they are often a 
main object of studies and undergo investigation with the application of multiple 
techniques, from biochemical, pharmacological to microscopic ones. Most of the 
methods, unfortunately, provide averaged data that are based on a vast number of 
particular events. Additionally, frequently little information can be gained at all as the 
amount of studied molecules is below the detection level of the technique (<1000 
molecules/cell). In such cases, any data from the biochemical assays vast volumes of cells 
are required and this either do not guarantee success. Microscopy could be a much more 
powerful tool regarding the resolution and sensitivity level to localize particular 
membrane proteins, however, there occur restrictions as well, concerning for example 
the necessity of in situ labeling like for the electron microscope measurements. A craving 
for in vivo approach with improved temporal resolution by microscopy has lacked so far 
the sensitivity and resolution to achieve the final goal: to follow a single receptor in living 
primary cells. 
Recently, the advent of new labeling methods with small, fluorescent 
semiconductor nanocrystals, quantum dots, makes it possible to monitor single receptors 
in the membrane of living cells (1). QDs are 100-fold brighter than standard 
fluorophores, have a photostability of many hours, a relatively small size that is not much 
bigger from the common fluorescent proteins and an availablility in many colors with 
ultraviolet or blue light excitation. Furthermore, QDs are commercially available  with 
different biological functionalities (2,3). 
The main benefit from the brightness and stability of the QDs is that single protein in 
vivo imaging becomes to be possible because the relatively low excitation power induces 
little cellular background allowing for high signal-to-noise ratios (exceeding 100:1) and 
thus sub-resolution limit “pointing accuracy” (4). What is more, QDs are rich in the high 
electron density enabling the primary cell or tissues samples to be subsequently fixed and 
re-imaged with high resolution electron microscopy (5). All mentioned reasons introduce 
quantum dots as a powerful tool that is able to bring a fresh insight into membrane 
receptor biology (6-11) and resolve fundamental doubts about cell data of such low 
receptor density.   
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However, reports of quantum dots for single-molecule tracking have not been 
consistent with a CCD camera system so far and the parameters required for the QD 
visualization on the cells have not been optimized. This is in contrast to other fluorescent 
techniques such as Fluorescence Correlation Spectroscopy, FCS (12). Defining and 
optimizing parameters for quantum dots in single-molecule microscopy seems to be 
requisite to acquire the best for the tracking detection level. For various natural and 
artificial fluorophores these parameters have already been reported (13,14,15). 
 QDs have one main feature, which occurs at times more pronounced than from 
standard fluorophores and which can be described as the emission rhythm based on the 
constant change between the ‘on’ state and intervals with no emission at all. This on-off 
situation is called ‘blinking’ and apart from it, QDs undergo photobleaching under 
continuous but albeit long perods of excitation (16), attributed to Auger ionization 
(16,17), but this process is not well understood (18-22). Continuous blinking could also 
be a serious incommodity in the analysis based on signals from individual quantum dots 
or their conjugates in flow cytometry or single-molecule biochips (23). The ‘off’ state of 
some QDs during measurement could decrease an overall signal to significantly alter 
stoichiometry measurements. In single tracking experiments blinking process has a 
special meaning as it can disturb acquiring the trajectories of maximal length. 
In this investigation the photophysical behavior is characterized and the most 
optimal conditions for the quantum dot usage in single-molecule microscopy are 
determined. For the first time, we present the stoichiometry and mobility of individual 
interleukin receptors, the IL-5RβC on living eosinophil-like cells. 
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3.2. Results & Discussion 
 
 
 
3.2.1. Quantum dot properties 
The first inevitable step in the examination of quantum dot photophysical 
characteristics was to determin the concentration in which the single QDs could be 
detected. Concentration dependent 2D samples of QDs were created (Figure1). At the 
lowest concentrations (1 pM, Figure. 1) single QDs and single-step photobleaching, 
‘blinking’  were observed (13,24). 
 
 
Figure 1. Fluorescent images of QD655. Solutions of the indicated concentrations of QDs in 
borate buffer with bovine serum albumin were spincoated with 10 µl each on a glass 
coverslip. Upper row presents scaling to the level where single molecule are observed; 
bottom row is scaled to show the full intensity range of each image. All images were recorded 
at 1 kw/cm
2
 for 5 ms. 
 
 
In order to catch the moment when a molecule achieves a dark state and stops 
emitting individual QDs were tracked in sequential images for longer time periods to 
imitate in vivo recording times. Photobleaching was observed when the fluorescence does 
not come back  after a while; and the blinking, when the fluorescence does re-appear.  
The periodic character and intensity fluctuation of the QDs were outlined. From 
the data it was concluded that the blinking off time follows power law statistics:  
 
where P(t) is the off time probability, t is the time of any ‘OFF’ event and α is 
descriptive exponent. Blinking statistics can solely be well-defined if a lower time cutoff 
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is verified for them. A lower cutoff time could could shape the means to determine the 
distribution. In our experiments, this time was reached by the readout time (our 
minimum is found between 10 and 30ms) and signal-to-noise ratio of our CCD camera 
imaging system under single-molecule tracking conditions. The statistics of blinking 
events, however, should be separated from the fact that dark, non-fluorescing QDs exist 
(12,26) and also that some can be photoinduced (25).   
To distinguish the various effects of blinking and intensity dependent 
photoinduction of quantum dots, an excitation dependent investigation was conducted in 
which QDs were mapped out spatially concerning the excitation intensity, Iex, to ascertain 
if more QDs in diverse positions are excited with higher intensity and whether they are 
excited more often. (Figure 2 and 3). 
 
 
Figure 2. Fluorescent properties of quantum dots QD655. (A) Total number of QD655 
photoinduced and recorded within a 32 x 32µm area as a function of Iex. Application of 
excitation intensities above 1 kW/cm² does not cause a significant further increase in number 
of QDots. (B) Activation of fluorescence by increasing Iex. Plotted is the total number of signal 
positions obtained in 1000-frames (5 s with 5 ms per frame) datasets. Data were fitted to the 
saturation equation given in the text to reveal N
∞
=121773, the maximum number of 
observations, and IS =0.1675 kW/cm
2
 the intensity where 50% of the total positions were 
observed. Signal positions (±0.5 pixel) at multiple frames were only counted once. 
 
 
The results in Figure 2 and 3 demonstrate that increasing the excitation intensity leads to 
increasing numbers of individual spatially separated QDs achieving saturation above ~1 
kW/cm2. Before data acquisition the sample regions in the experiment were illuminated 
for 30 seconds with excitation >5kW/cm2. We discovered this procedure to be necessary 
and sufficient to photoactivate the portion of QDs which became dim due to long 
periods of photoinactivity (25). The saturation intensities (IS) that describe the excitation 
 70 
intensity where 50% of the total fluorescent QD population begin to emit are 0.14±0.03 
and 0.17±0.05  kW/cm2 for Figure 2 A & B, respectively.  
 
 
Figure 3. Example of the overlay of the signal positions. Detected signal positions in one 
focused sample region of spin coated QD655 on a glass coverslip at increasing excitation 
intensity. The data were fitted in 1000 frames datesets to count the total number of the 
photoactivated QDs. Data shown here were recorded over the same area at two Iex – 0.14 
(green circle) and 1.44 (red plus) kW/cm
2
. The higher excitatoin intensity revealed twice as 
many positions. 
 
It was shown also that blinking varied with excitation intensity and exposure 
time. Intensity traces (Figure 4A) were created from the total fluorescence values of 
integrated fluorescence from particular QDs. Application of power law statistics to ‘ON’ 
and ‘OFF’ data at individual excitation intensities proved that the power law exponent is 
large enough that a finite mean could exist for ‘ON’ and ‘OFF’ distributions.  
At Iex > 1 kW/cm
2 shorter mean ‘ON’-time periods were noticed in agreement with 
Figure 5A. The dependence of ‘ON/OFF’ time on excitation intensity follows the 
saturation model: 
 
where IS is the half-maximal saturation intensity, a = 1 for τon and -1 for τoff, and  τon /off(∞) 
is the ‘ON/OFF’ time at infinite excitation intensity (13,14). Increasing the excitation 
intensity enhanced QD blinking. The ‘ON’ periods became shorter, IS
on = 0.80 
[kW/cm2], until the ‘ON’ periods reached a plateau of τon(∞)= 0.19 seconds. However, 
the average ‘OFF’ periods increased solely moderately, IS
off=0.66 [kW/cm2], with τoff(∞)= 
0.24 seconds. We also observed that the trend for very long traces or even completely 
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non-blinking individual QDs was much greater at lower excitation intensity (Figure 5B). 
This indicate that a few particular QDs will never or less frequently blink during 
recording periods and will only begin to blink at higher (> 1 kW/cm2) excitation 
intensities. Quantum dots, their fluorescence and blinking are fully dependent from the 
excitation intensity. 
 
 
 
Figure 4. Examples of fluorescence intensity time trajectories. Increasing excitation 
intensity increased quantum dot emission but also start to blink more intensively - the ‘ON’ 
periods shorten and occur less frequently. This tendency is also clearly seen when the mean 
blinking ‘ON/OFF’-times are plotted as a function of the excitation intensity 
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Figure 5. (A) „ON“-times (open squares) - τon
∞
= 0.19 seconds, IS=0.80 kW/cm
2
. “OFF”-times 
(filled circles)- τoff
∞
= 0.24 seconds, IS=0.66 kW/cm
2
. (B) Number of traces longer than 75 
uninterrupted frames observed within the average 1000 frame dataset. The trend shows the 
increase of blinking and reduction of the trace length with increasing excitation.  
 
 
QDs present multiple levels of emission particularly at higher excitation 
intensities (Figure 6A , 6B) (17). It is clear to notice that at excitation intensities > 1 
kW/cm2, the emission distributions contains multiple maxima. An Auger process is 
proposed to be responsible for that – i.e. that QDs lose electrons under high excitation 
and have lower emission or even photobleach (17,18). To study various fluorescence 
states and saturation, the fluorescence of the single QDs from 2D Gaussian fits was 
averaged from all individual observations in a dataset (Figure 6C). The excitation 
intensity-dependent fluorescence <F(I)> obeys the saturation model: 
 
where IS is the half-maximal saturation intensity and F0 is the maximum fluorescence. 
Emission increases  in the excitation range with IS = 10.8; 2.9 and 0.8 [kW/cm
2] for 
QD655, EviDot603 and QD525, respectively. The saturation intensities are lower than 
the values reported by Doose et al. (12) by a factor of ~5 due to the difference in the 
time-scale. QD525 and EviDot603 had fluorescence of 10x and 20x less than QD655, 
what is attributed to the absorption coefficients which are reduced approximately by the 
same amount as that of QD655 at the corresponding excitation wavelengths. Hence, the 
fluorescence emission rate of the different QD types varies vastly and the excitation 
saturation intensities of the different types  roughly follow the order of absorption 
coefficients.  
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Figure 6. Fluorescence intensity probability distribution of QD655. Each probability 
density function, ρ, represents the distribution of the fluorescence signal intensity of at least 
2000 individual observations of spincoated QDots. With increasing excitation intensity the 
probability to excite other fluorescence states greatly increases. (A) QD655 (B) EviDots603 
(C) Saturation curves for the single QD fluorescence emission rate (photon counts/5ms) as 
function of the excitation intensity (Iex). QD655(triangles): F0 21045 photon counts/5ms, IS ~ 
10 kW/cm
2
; EviDot603(squares): F0=1126.90 counts/5ms, IS =0.80 kW/cm
2
; QD525(circles): 
F0 = 580 counts/5ms, IS =2.9 kW/cm
2
. (D) Distribution of the fluorescence signal intensity 
constructed from 2133 individual observations of spin-coated QD655-biotin:avidin 1:1 molar 
ratio mix (grey filled bars) with corresponding probability density function, ρ (black curve) with 
Iex = 0.7 kW/cm
2
. The distribution was fitted for the signal intensities to 6 Gaussians (dashed 
light grey line). For comparison, the intensity distribution (light grey bars) obtained from 
QD655-Biotin solution without clustering by avidin displayed a corresponding probability 
density function, ρ (dashed curve). The positions of the maxima in the distribution were 
equidistant with a slope of 383 counts/5ms (inset). 
 
3.2.2. Dark quantum dots and QD clustering 
It has been previously described that some QDs are completely dark (26), thus 
we decided to investigate this fact. For that reason we placed QDs on transmission 
electron microscopy (TEM) grids and juxtaposed the mean fluorescence of multiple 
regions of QDs on the grids acquired on the fluorescence microscope to the actual QD 
number counted from TEM imaging (Figure 7). 
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The TEM images show a mean density of ~ 1100 QDs/µm2. The mean 
fluorescence was 6500 counts/10ms/pixel with a pixel area of 0.04µm2. We observed 
that the average QD655 emits ~700 counts/10ms and that solely ~50% of QDs are 
excited (at Iex = 0.13 kW/cm
2) , we appraise the QD density by fluorescence at 450 
QDs/µm2 and that ~60 ± 10% of QDs were totally dark. A rod like shape (Figure 7C) 
was observed for all of the QD655 quantum dots which was in agreement with the prior 
reported shape of QD655 (5). We noticed about one cluster of two quantum dots per 
~30 QDs from the TEM images, what indicated no significant clustering of the QDs. 
 
 
Figure 7. Comparison of the fluorescence intensity wih the actual QD number. (A,B) 
Fluorescence image of a QD655 monomoloecular layer deposited on an EM Grid and 
corresponding transmission electron micrograph, TEM (C). Scale bar: 10 µm (A), 1 µm (B), 
0.01 µm (C).  
 
 
3.2.3.Stoichiometry with quantum dots 
Fluorescence distribution can predict and assay higher fluorescence levels of 
molecular clusters to determine local stoichiometry (24,27). That can be understood by 
contemplating the fluorescence distribution at Iex <= 1 kW/cm
2  which comprises of one 
level with a minor shoulder attributed to higher emission states and to the low number of 
naturally occurring QD clusters. To better characterize determination of the 
stoichiometry with the fluorescence distibution profile, we forced clustering of biotin-
coated QD655 with streptavidin.  
The fluorescence image of small QD clusters does not vary from an image of 
single dots, apart that it shows higher intensity. However, QD blinking has a significant 
impact on an average intensity of a QD cluster, reducing it and this way making a direct 
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fluorescence intensity count more complicated. Correspondingly to the example with 
chemical dyes (24,27), the probability density function of the fluorescence intensity 
displays a discrete structure and could be fitted with a sum of multiple Gaussians to 
indicate the stoichiometry of many clusters (Figure 6D and 8). However, due to the 
effect of totally dark (~50%) and blinking (~40%) QDs, a correction to these values 
must be included for which a binominal model is applied (24) with the general formula: 
 
where Pn  is the best approximated maximum monitored fluorescence distribution peak 
with n designating the soichiometry number, qn representing the pure fluorescence of the 
nth level and rn representing the relative amount at the q
n level. The next lower 
fluorescence level is then affected by the dark and blinking QDs from the high level 
stoichiometry and as well from the totally bright clusters: 
 
This process continues until the sum of the probabilities: 
 
reproduces the experimentally determined fluorescence stoichiometry distribution and 
relative values  
 
are subsequently obtaioned. If the constraint is set that:  
 
the relative values are the corrected stoichiometries. 
 76 
 
Figure 8. Local stoichiometry diagram. Intensity image in 3D showing different 
stoichiometry levels of a spincoated QD655-biotin:avidin 1:1 molar ratio mix that induced 
clustered “hot spots”. When imaged at low excitation intensity (0.14kW/cm
2
 in this example) 
the probability to excite higher fluorescence states is negligible. Corresponding fluorescence 
intensity counting analysis image. The local stoichiometry of the biomolecule complexes could 
be estimated from the intensity of the signal which is divisible by the intensity of fluorescence 
signal from one QDot. Scale bar: 5µm  
 
 
To assure that presented data concerning the determination of stoichiometry 
were correct, we decided to prepare stoichiometric templates, a short oligonucleotide 
(T19), in four different variants that covalently attached one, two, three or four QD655. 
The molecules were observed on transmission electron microscope and next their 
fluorescence was measured on the fluorescent microscope. This way a kind of QD 
dependent intensity ‘scale’ was obtained that could be utilized as the stoichiometry 
indicator in any experiments with 655 quantum dots under parallel conditions. (Figure 9). 
Concerning particular subtypes of the templates, we measured also a mean fluorescence 
from several different regions containing many QD-oligonucleotide. The fluorescence 
distribution in cases of the sample with the higher QD number affixed to the nucleotide, 
i.e. QD2T19, QD3T19 and QD4T19 revealed that the purification of those samples was not 
fully completed and each of them embodied also some amount of molecules of the lower 
complex grade respectively. 
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         A                B                 C                     D                       E 
 
 
Figure 9. QD stoichiometric templates. Transmission electron microscope images of one, 
two, three and four QD655 that in each case are bound to the same type of 
oligonucleotide(A); Fluorescence images of the QDs from A (B); Fluorescence intensity 
scaling presenting different stoichiometry levels (C,D); Average fluorescence distribution for 
the each type of the template, created from the measurement of many different regions of the 
samples and indicating the presence of the molecules with lower number of QD attached in 
the samples of higher number QDs (E). 
 
 
 
We wanted to implement this analysis to a biological example. Microscopy of IL-
5RβC  interleukin receptors on living eosinophil-like cells requires single-molecule 
sensitivity due to the very low endogenous level of the receptors on the cell surface, 200-
600 receptors per cell (28), but also requires a strong fluorophore because of the very 
high autofluorescence background. Observation attempts with organic dyes have not 
been possible (Figure 10). 
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Figure 10. High autofluorescence background of eosinophil-like HL-60 cells. The 
detailed fluorescence microscopy of the IL-5/IL-3/GM-CSF receptor-ligand system is 
complicated. Two examples present the fluorescence images of eosinophil-like HL-60 cells 
taken before (left panels) and after (right panels) addition of the IL-5-TAMRA (tetramethyl 
rhodamine) conjugate. Even increased excitation intensity Iex do not caused a single-molecule 
pattern. The background signal was essentially indistinguishable from the signal of the 
fluorophore. Scale bar: 1µm  
 
 
IL-5RβC is the common receptor subunit in the interleukin-5 (IL-5) receptor 
system, of which high-affinity α-chain achieves specificity (29) (Figure 11). The receptor 
subunit is a single transmembrane spanning domain protein, has no intrinsic intracellular 
catalytic domains, and initiates signaling cascades through associated protein kinases. In 
humans, IL-5 plays important roles in proliferation, differentiation (30-32), migration 
(33), activation (34,35) and survival (36-39) of eosinophil-like cells. IL-5 is also crucial for 
inflammatory processes associated with general immunity and particularly with 
eosinophils, e.g. eosinophilia and allergic asthma (40).  
 
  Figure 11. The Interleukin-5 receptor 
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Identification of IL-5RβC on living cells with specific antibodies conjugated to 
QDs enabled to quantify the local stoichiometries of diffraction-limited regions with 
quantum dots in vivo and to gain information on receptor clustering (Figure 12). 
 
Figure 12. IL-5 receptor βc clustering. Distribution (blue bars) and the corresponding 
probability density function ρ (green curve) of the fluorescence signal intensity created from 
8185 independent observation on the eosinophil-like HL-60 cells. The data support that on the 
surface of the IL-5 receptor βc occur with high probability ic clusters of 4 and higher as 
determined by the correction algorithms for blinking and dark QDs (27). For comparison the 
probability density function ρ1 (red curve) for the intensity distribution of the non-clustered 
QD655-biotin solution obtained at the similar excitation intensity (0.52 [kW/cm
2
] is presented. 
 
From the area of integration of the individual Gaussian peak components the 
predominant component appeared to be fluorescent trimers with ~25%, followed by 
fluorescent tetramers with 19% and fluorescent dimers with 14%. However, upon 
accounting for the ~40% of blinking and ~60% of totally dark QDs in a binomial model, 
a maximum of clustering was found to be at a stoichiometry of 4, meaning prominent 
tetramer or higher order complex formation of these receptors in the eosinophil-like HL-
60 cells.  
 
 
3.2.4. Single Molecule Tracking of IL-5RβC  
Figure 13 depicts IL-5RβC tracking on eosinophil-like HL-60 cells. The individual 
receptor clusters with QD655 were easily seen over time on the cell surface. Under low 
Iex conditions it was possible to obtain a high number of long trajectories and low auto-
fluorescence background. IL-5RβC was measured with a signal-to-background ratio of 
>100, resulting in a positional accuracy of 3.4 nm. 
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IL-5RβC tracking exhibited two types of confined motion. First, there were 
regions from 300 up to 1400 nm in diameter where the receptors move with a fast 
diffusion coefficient (Dlat = 0.363 ± 0.035 µm²/s). Second, there were smaller confined 
regions with a diameter of 40-100 nm where the receptors moved with Dlat of 0.071 ± 
0.005 µm²/s.  
 
 
 
 
Figure 13. QD-IL-5 βc imaging and tracking on living eosinophil-like HL-60 cells. (A,C) 
The bright spots (or “hot spots”) indicate the location of individual IL-5 receptor βc subunits. 
Dim areas in the images represent background noise and background autofluorescence of 
the cell. Trajectories of clearly distinguished signals are shown as overlay. Data acquisition 
rate was 33.5 ms per frame. Scale bar: 2 µm (A); 1 µm (C); 1 µm (B). (B) Specific labeling 
control. The figure presents a cell subjected to the same labeling procedure without of anti-βc 
Ab. D) Representative single-molecule trajectory showing two types of confined motion of the 
individual IL-5 receptor βc subunits visualized with the help of a mouse anti-βc antibody and 
goat anti-mouse QD655 conjugate. 
 
 
 
To verify that mobility and high cluster formation of IL-5RβC receptors was not 
infuenced or induced through QD-antibody labeling technique, we decided to produce 
suitable QD-Fab fragments suitable for this labeling and to compare fluorescent images 
(Figure 14, A and B). In both cases clusters of receptros were onserved. Additionally, for 
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the control, we labeled and measured another receptor on HL-60 cells that we  known to 
be non-aggreagating (Figure 14C). That definitively proved that it was not a labeling 
method to initiate IL-5RβC  receptors clustering, but natural way in which this receptors 
occur at the cell membrane. 
 
 
A 
 
 
B 
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C 
 
 
Figure 14. Verification of the IL-5RβC receptor mobility and clustering type. IL-5RβC  
mobility and clustering pattern after receptor labeling with QD-monoclonal antibody (A); 
Labeling of IL-5RβC was performed with QD-Fab fragments. Observed clustering was very 
similar to A (B); Non-aggreagating receptor profile on HL-60 cells proved definitively that 
clustering is a natural way of occurance for IL-5RβC  receptors.(C); Scale bar: on all bigger 
images 5 µm, on smaller 1 µm. 
 
 
3.2.5. Discussion  
The conditions for the optimal use of QDs were the main subject of this study. 
We have tested commercially available QDs to best apply them for single-molecule 
tracking. With the optimal excitation parameters, QDs produce extremely long 
trajectories of over 100 uninterrupted frames (5 ms/frame, ie. 500 ms). We clearly show 
the utility of these parameters in microscopy and present a direct example with the 
tracking and local stoichiometry determination of IL-5RβC interleukin receptors on living 
eosinophil-like cells. 
Our work demonstrates that despite blinking and ~60 ± 10 % of totally dark 
QDs, individual quantum dots under an excitation intensity of just below 1 kW/cm2 have 
in general higher emission rates than many of the standard fluorophores. In vivo, single-
molecule fluorescence experiments require the highest signals with the highest excitation 
percentage and lowest photobleaching, blinking, and autofluorescence levels. By 
choosing the condition of ~ 1 kW/cm2 with 5 ms excitation, we were able to easily 
obtain average, uninterrupted trajectory lengths from 15 to over 100 steps with > 10% of 
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the whole population not blinking at all (at 5 ms/image) – at least five to twenty times 
longer before an ‘OFF’-state than the best commercially available organic fluorophores. 
This condition also ensures that roughly 40% of all QDs will be observed.  
Although longer traces can be recorded from metallic nanoparticles with 
ultimately lower time resolution, multiple-color-localization and analysis of stoichiometry 
are only possible with QD fluorescence tracking. Under our optimized conditions, we 
had signal to background ratios exceeding 100:1 what allows positional accuracy of <4 
nm. The minimum imaging exposure time can be reduced depending on the noise and 
sample background. Typical minimal values are as low as 1 ms. The emission wavelength 
of the QDs and the manufacturer also play a role in fluorescence brightness and 
photoinduced activation. The red-shifted QD655 from QDot Corp. is > 10x brighter 
than QD525 (QDot Corp.) and EviDot 603 (Evident Technologies), and also the 
QD655 and QD525 are more easily photoinduced than EviDot603. 
In comparison to other fluorophores by our previously defined R-value, a 
benchmark of how many molecules it would take to mask the emission of a single, 
emitting fluorophore, the QD versus flavin fluorescence ratio is apparently >105, in 
comparison to eYFP with a ratio of 405 (13,14). (Flavin is the chief component of 
cellular autofluorescence in vertebrate cells.)This can be interpreted that for cells 
containing high levels of flavins, it may still not be possible to detect single QD655 or 
individual quantum dots because the background is too high, but that QDots are much 
better than other standard fluorophores (13,14). This limitation for QDs could be 
overcome by bleaching the cells for longer periods because the bleaching half-life of 
QDs is ~14 hours at ~ 1kW/cm2, whereas flavins and other endogenous fluorophores 
bleach within a few seconds at this light intensity. 
Achievements of single molecule sensitivity by fluorescence permit a detailed 
analysis of local stoichiometries directly on the surface of the live cells. The stoichiometry 
of the IL-5 receptor-ligand signaling complex determined this way is valuable as a 
complement to the crystallographic structure of the interleukin receptor-ligand complex. 
Resolution of the 3D structure for the recombinantly expressed extracellular domain of 
the receptor βC reveals a stable intertwined homodimer (41,42) raising concerns over 
previously postulated 1:1:1 stoichiometry models of IL-5:IL-5Rα:βc (29,43,44). From 
biochemical separation methods with soluble Granulocyte-Macrophage Colony 
Stimulating Factor Receptor (hGM-CSF-Receptor-α) and the extracellular soluble part of 
βC, one GM-CSF is recognized by one hGM-CSF Rα with recruitment of 2 molecules of 
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βC (45). Our results suggest that on native and comparatively natural, undisturbed cellular 
surfaces, non-active IL-5RβC may be aggregated in clusters of four and more subunits 
suggesting more complex activation mechanisms than previously anticipated. This 
example further shows that QDs allow the detection of low levels of endogenously 
present biomolecules in a very difficult, physiologically native environment. 
We expect that QDs will be the fluorophore of choice for standard single-
membrane protein stoichiometry and tracking studies, and that they can be further 
improved by solving limitations that this study quantifies such as blinking and dark states. 
Using our optimized methods, they can already now be used to visualize single-molecules 
under difficult conditions. 
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3.3. Materials and methods 
 
 
 
3.3.1. Quantum dots 
QD525, QD655  Biotin or Streptavidin conjugates were acquired from QDot 
Corporation, Hayward, CA and EviDot603 (EviTags Fort Orange-COOH) were from 
Evident Technologies, Troy NY, USA. Avidin was from Sigma (Sigma-Aldrich, 
Germany). 
 
3.3.2. Complex preparation 
To model receptor clustering we induced restricted aggregation of QDs. 10 µl of 50 pM 
avidin solution in 50 mM borate/HCl pH 8.3 was added portionwise to 10 µl of 2 nM 
suspension of QD655-Biotin in same buffer (molar ratio 1:4). The reaction was 
performed at 4°C with intensive shaking. 
 
3.3.3. Films and Spin Coating 
For the spincoating the 2 nM (or 1 nM in a case of the complex suspensions) of QD 
suspensions were serially  diluted 1:10 to create concentration steps from 2*10-9 to 2*10-12 
in either 1% polyvinyl alcohol (PVA, Roth Chemicals, Germany) aqueous solution or in 
50 mM borate/HCl pH 8.3 buffer containing 0.1% bovine serum albumin. Mono-
molecular layers (spincoats) were created on cleaned glass slides by adding 20 µl of the 
fluorophore solution with a spin coater (SPI, KW-4a, PA, USA) in two stages: first for 10 
seconds at 300 rpm and then for 2.5 minutes at 2,000 rpm.  
In all cases, the glass coverslips were cleaned in 10% NaOH (AppliChem, Germany) with 
sonication for 10 minutes and rinsed in 18 MOhm-water (Millipore, USA) prior to use. 
 
3.3.4. Cell culture 
Eosinophilic cells (15HL-60E) were obtained as previously described (46). In brief, the 
HL-60 clone 15 cells (ATCC Cat. No.: CRL-1964) were grown in RPMI1640 medium 
supplemented with 10% FCS, 25mM HEPES pH7.6 and antibiotics and differentiated in 
the same medium with 0.5mM sodium butyrate (Sigma-Aldrich, Germany) for at least 
one week. 
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3.3.5. Single-molecule imaging 
The experimental arrangement for single-molecule imaging has been described in detail 
previously (13,14,24). The samples were mounted onto an inverted microscope (Zeiss, 
Axiovert 200, Germany) equipped with a 100× objective (NA=1.4, Zeiss, Germany), and 
illuminated for 1-30 ms by an Ar-laser (Coherent Innova 308, USA) synchronized with 
the exposure of the Peltier-cooled CCD-camera system (Spec-10, 400B or 1300 B, Roper 
Scientific, USA). The synchronization was achieved with custom-built electronics 
between CCD-camera-exposure and shutter, and  acousto-optic time-frequency 
modulator (AOTF, AA Optic, France). The following filter combinations were used: 
DCLP525 and HQ655/40 (Chroma, VT, USA) or OG550 (Schott, Germany) for 
QD655  and Evitags 603, DCLP498 and HQ 525/50 for QD525 (Chroma, VT, USA). 
The total detection efficiency of the experimental setup was ~13% for QD655 (and ~ 7 
% for Evitags 603 and QD525). The photon counts were determined with a precision of 
~ ±15%.  
Same sample regions of individually resolved QDots were recorded in sets of 1000 
consecutive images illuminating and exposing for 5 ms with recording each set at one 
illumination intensity from 0.05 to 5 kW/cm2. These are typical value ranges for the 
observation of single quantum dots and other fluorophores. Longer and shorter 
integration periods were tested but not reported here as they lead to the same 
conclusions. 
 
3.3.6. Data and mobility analysis 
Data processing and mobility analysis were conducted like in aforementioned protocols 
in points 1.3.7. and 1.3.8.  
 
3.3.7. Immunolabeling 
An aliquot of  (1•106) 15HL-60E cell suspension in culture medium was incubated at 
37°C, 5%CO2 for 20 minutes in the presence of 400 ng/ml non-blocking anti-βC-mouse 
monoclonal IgG1 (1C1, sc-21765 Santa-Cruz Biotechnology, USA). The suspension was 
washed with RPMI1640 (Sigma) and resuspended in RPMI1640, 0,3% Ig-free BSA plus 1 
nM QDot™655 goat F(ab’)2 anti-Mouse IgG  conjugate (QD Corporation, Hayward, 
CA). After 10 minutes incubation (37°C, 5%CO2), cells were washed twice with 
prewarmed RPMI1640 for 1 min with centrifugation (1•103 rpm, 37°C) (Eppendorf). 
Cells were imaged in RPMI1640 at 37°C. 
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3.3.8. Fab-QD655 Fragment production 
Fab fragment of IL3/IL-5/GM-CSFRβ antibody (Santa Cruz Biotechnology, sc-21765) 
was  produced with Fab Preparation Kit (Thermo Scientific) and ICONTM Concentrator 
(Pierce) and next conjugated to QD655 with the usage of Qdot Antibody Conjugation 
Kit (NrQ22021MP; Molecular Probes, Invitrogen Detection Technologies, Eugene, 
Oregon, USA; Invitrogen, Karlsruhe, Germany) . 
 
3.3.9. TEM Imaging 
Electron micrographs were taken from dried films containing QDots at 80kV with a 
Zeiss EM900 transmission electron microscope. 
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 4  
 
 
PTHR – parathyroid hormone receptor mobility, 
internalization and recycling in single-molecule studies 
 
 
 
 
 
 
The receptor for parathyroid hormone (PTH) and PTH-related protein (PTHrP) 
is entailed in the regulation of calcium homeostasis and in bone remodeling (1). Agonist 
occupancy of the PTH/PTHrP receptor (PTHR) leads to activation of adenylyl cyclase 
(via Gs), and phosphatidylinositol-specific phospholipase Cβ (via Gq). PTH-induced 
activation of the PTHR results in the internalization of the PTH-receptor complex via 
the clathrin-coated pit pathway and engages β-arrestin2 (2,3). 
Internalization, in general, enables to diminish the magnitude of the receptor-
mediated G protein signals (desensitization), receptor resensitization (via recycling), 
degradation (down-regulation), and coupling to other signaling pathways (e.g. MAP 
kinases).  
GPCR internalization process maintains still one of the most addressed, 
particularly regarding the determinants that are involved.  
In this study we tend to stare at the parathyroid hormone receptor type 1 mobility on 
living cells in order to better characterize its internalization and as well to follow its 
recycling dynamics. 
 
 
 
 
 
 
 
 
 
Manuscript in preparation 
Zelman-Femiak M,  Harms GS 
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4.1. Introduction 
 
 
 
The parathyroid hormone receptor type 1 (PTHR1) belongs to Family B of the 
seven transmembrane G protein-coupled receptor (GPCR) superfamily and is activated 
by two ligands, parathyroid hormone (PTH) and PTH-related protein (PTHrP). The 
intracellular tail domain of the PTHR1 contributes to G protein subunit coupling that is 
important for second messenger signaling. PTHR1 signals through several second 
messenger pathways, including adenylyl cyclase and phospholipase C. 
PTH-induced activation of the PTHR results in the internalization of the PTH-
receptor complex via the clathrin-coated pit pathway and is the consequence of the 
formation of a complex between β-arrestin2, the clathrin adaptor protein AP2, clathrin, 
and the activated receptor. Internalization has at least two outcomes: directing the 
receptor to a compartment where the phosphates are removed, allowing resensitization 
via recycling, and movement of the receptor to lysosomes for degradation (4). 
Intact PTH 1–84 is a key endocrine regulator of calcium homeostasis and is 
secreted by parathyroid cells in response to reduced ionised calcium in the blood and, 
with its cleavage products (providing the N-terminus is preserved), activates the 
PTH/PTHrP receptor found in key target organs. The receptor is expressed, among 
other cells, by osteoblasts, osteocytes and bone-lining cells, and activates distinct G 
protein signaling cascades by coupling with either adenylate cyclase, phospholipase C or 
cAMP/protein kinase A depending upon the cell type (5-8). The receptor is also 
responsive to parathyroid hormonerelated peptide (PTHrP). C-terminal fragments 
(formed by intracellular cleavage both within the parathyroid and in target organs of 
PTH) form the major circulating fraction because of their low catabolism. Although, the 
biological actions of C-terminal fragments are unclear, they appear to have a distinct 
receptor (9), to enhance osteoblast activity in culture (10) and to be highly expressed in 
osteocyte-like cells (11). 
The parathyroid cell is sensitive to changes in extracellular calcium 
concentrations, with small increases in extracellular calcium inhibiting secretion of PTH. 
Conversely, a decrease in extracellular calcium steers to a rapid increase in PTH 
secretion. Characterization of the surface calcium-sensing receptor of the parathyroid cell 
showed a large extracellular domain for binding cations (12), with activation of the 
receptor via G protein coupling (13). Activation leads to rapid mobilization of 
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intracellular calcium via inositol triphosphate, with acutely elevated cytoplasmic calcium 
responsible for inhibiting PTH exocytosis (14). Receptor binding and potentiation by 
calcimimetic drugs increase the receptor sensitivity to calcium and results in decreased 
PTH secretion, with results from clinical trials suggesting efficacy of such drugs in 
treating primary and secondary hyperparathyroidism (15,16). Conversely, calcilytic 
compounds developed to antagonise the calcium receptor are a potential new 
pharmaceutical means of creating an endogenous surge of PTH for anabolic bone 
effects, as seen in a recent animal study (17). Mutations of the calcium-sensing receptor 
(both gainof-function (18), and loss-of-function (19)) can result in either autosomal 
dominant hypocalcaemia (18) or familial hypocalciuric hypercalcaemia (19). 
It is now possible to synthesize either the whole PTH molecule or specific 
fragments by recombinant technology. Initial studies with PTH, however, used PTH 1–
34 (teriparatide) as it was thought to be similar to the natural cleavage product and 
retained the bioactivity of PTH 1–84 in bioassay. More recent studies with PTH 1–38 
(20), PTH 1–84 (21) and PTHrP 1–36 (22) have suggested potential new applications 
with fragments of different structure, what is particularly intriguing given the distinct 
actions of the C-terminal fragment present in PTH 1–84 (21). The majority of clinical 
studies with PTH as a treatment for osteoporosis have involved parenteral 
administration; however, in one study, PTH 1–34 was delivered by direct plasmid gene 
incorporation of PTH 1– 34 and expression by fibroblasts for the in vivo treatment of 
bone defects (23).  
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4.2. Results & Discussion 
 
 
 
To study the parathyroid hormone receptor (PTHR1) behavior at the plasma 
membrane of living cells, its mobility pattern and an internalization rate, we applied 
single-molecule tracking that is an appropriate technique for the spatial-temporal 
investigation such as signal transduction and the molecular complexes formation.  
Cos-1 and AD293 cells were transiently transfected with the ACP-PTHR 
construct, the acetyl carrier transferase protein fusion to the N-terminus of the human 
parathyroid hormone receptor. That allowed for a covalent labeling of the receptor with 
quantum dot-CoA and entirely maitaining the receptor activity (see Captions 1.1-1.4).  
We tested PTHR1 under stimulation with five peptide ligans, specific fragments 
of PTH: hPTH(1–34), hPTHrP(107–111)NH2; PTH(1–14);
 PTH(1–28) G1R19, bPTH(3–
34), from which the first four are known to belong to PTH agonist group and the last is 
an antagonist. Ligands were applied in the concentration range from 250pM to 250µM, 
with ten-fold increment for particular experiments. Data were gathered on the 
fluorescent microscope up to 30 min after receptor ligand stimulation. 
According to the foremost observation, within 30min after ligand application 
receptor internalization occurred (Figure 1). We could follow the receptor not only at the 
cellular membrane but also inside the cell.   
 
 
Figure 1. QD-ACP-PTHR1 receptor internalization. Fluorescence images of labeled at the 
cell membrane receptors (A); receptors are at the membrane (left panel) and 20 min after 2.5 
nM PTH/1-28/ the internalization process is registered (right panel) (B) 
 
The rate of internalization depended on a ligand-type and applied concentration. 
The mean value of internalizing molecules was callculated on the base of five 
independent experiments and obtained for all ligand types and concentrations. Here, an 
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example of the internalization profile is presented for 2.5 nM ligand concentration 
(Figure 2).  
 
 
Figure 2. QD-ACP-PTHR1 receptor internalization profile for 2.5 nM ligand 
concentration.  Data shown are from five independent experiments. 
 
 
 
No significant changes, no internalization events, were observed after application 
of bPTH(3–34), the PTHR receptor antagonist. Attached QDs ‘shaked’ only, showing 
almost no movement. 
After stimulation with hPTH(1–34) PTHR receptor mobility was restricted to the 
region of a small confinement and reminded trembling, however in this case 
internalization was observed, for example after 15min for 250pM hPTH(1–34), already in 
2 min  for 2.5nM and in 5 min for 25nM. 
Application of 250nM hPTHrP(107–111)NH2 resulted in a full interlization of 
QD-receptor complexes by the time of 7 min, whereas stimulation with the same 
concentration of PTH(1–28) G1R19 and PTH(1–14) produced the same effect already 
after 2 and 5 min, respectively. 
Higher concentration of PTH analogues showed also tendency to increased 
trajectories (Figure 3). Interestingly, higher ligand concentration also caused a sudden and 
short but complete immobilization of the receptors.  
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Figure 3AB. Trajectories of particular QD-ACP-PTHR receptors after ligand stimulation. 
Example of 0.25 nM (A) and 2.5 nM (B) concentration of PTH/1-34/ ligand application 
 98 
 
 
 
Figure 3C. Trajectories of particular QD-ACP-PTHR receptors after ligand stimulation. 
Example of 25 nM (C) concentration of PTH/1-34/ ligand application 
 
 
During microscopic measurement also recycling process appeared. The fastest time after 
which receptor recycling occured, was registered 10min after ligand addition (Figure 4). 
 
 
Figure 4. Example of the particular QD-ACP-PTHR that recycled. After application of 2.5 
nM PTH/1-28/ G1R19 observed QD-receptor internalized in 10 min and returned at the 
membrane in t=20 min. Ten minutes receptor was internalized. The next internalization was 
noticed at time t=30 min. 
 
 
Regarding mobility analysis we could not state extreme differences in MSD 
versus time plots for PTHR when compared ligands between in each other in 
appropriate concentrations. Figure 5 displays the example of MSD plot for PTHR after 
PTH(1–14).  
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Figure 5. Example of QD-ACP-PTHR mobility characteristic when 2.5 nM PTH/1-14/ was 
applied. The graph presents the averaged MSD versus Time plots for all receptors from 5 
independent experiments.  
 
 
 
In all experiments it has been confirmed that not only the 34 amino acid peptide 
fragment of PTH activates the parathyroid hormone receptor at the cell membrane 
efficiently, initializing receptor internalization, but also other tested PTH fragments 
resulted in receptor activation. However, there was a slight tendency observed that the 
lowering activity occured from hPTH(1–34), PTH(1–28)G1R19 to PTH(1–14), what was 
measured with the internalization rate and the mobility of receptors. 
hPTHrP(107–111)NH2 showed the lowest efficiency. PTH(3–34) confirmed to 
be an antagonist for parathyroid hormone receptor as there was no internalization 
observed after its addition. Interestingly, in some cases PTH(1–28)G1R19 caused higher 
internalization rate and higher mobility of the receptors than teriparatide. 
 Taken together, applied single-molecule tracking enabled to scrutinize the 
parathyroid hormone receptor (PTHR1) behavior at the plasma membrane of living cells, 
to recognize its mobility pattern, define the internalization and recycling rates under no 
ligand stimulation as well as upon stimulation of respective peptide ligands.  
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4.3. Materials and methods 
 
 
 
4.3.1. Plasmid Contruction of ACP-PTHR 
The acetyl carrier transferase protein fusion to the N-terminus of the human parathyroid 
hormone receptor was produced in a similar manner as previously reported for the N-
terminally labeled GFP-PTHR (ref. Johnsson – ACP fusion labeling and Castro – GFP-
N-PTHR) following a PCR strategy using pfu DNA polymerase (Fermentas). cDNA 
encoding the N-terminal fragment of human PTHR (corresponding to amino acids 1-60) 
was amplified with primers containing restriction sites for HindIII (5’) and BamHI (3’). 
ACP cDNA (ref. Johnsson – ACP) was amplified without stop and start codons with 
primers containing restriction sites for BamHI (5’) and EcoRI (3’). cDNA encoding the 
fragment of human PTHR (corresponding to amino acids 102-593) (ref Castro) was 
amplified with primers containing restriction sites for EcoRI (5’) and EcoRV (3’) and 
also stop codon. All three PCR products were subcloned together by ligation after 
digestion with the same restriction enzyme in to pcDNA3 (Invitrogen) for transfection 
and expression in mammalian cells. The final construct did not include the 
pharmacologically un-important residues 61-101 but did include a six residue linker 
between the ACP C-terminus and PTHR N-terminus  (Arg-Leu-Ile-Ser-Gly-Ser). The 
subcloned in to pcDNA3 construct was verified by sequencing. 
 
4.3.2. Cell Culture 
African green monkey kidney cells (COS-1) and Human embryonal kidney cells (AD293) 
were cultured in DMEM - Duplecco’s Modified Eagle’s Medium (Sigma) supplemented 
with 10% fetal calf serum (PAA Laboratories GmbH) and 1% penicillin/streptomycin 
(Sigma) solution at 37oC/5% CO2. FuGENE 6 (Roche Applied Science) and Effectene 
Transfection Reagent (Invitrogen) were facilitated for COS-1 and AD293 cells transient 
transfections, respectively. For single-molecule-imaging cells were seeded into six-well 
plates containing glass cover slips (24mm, thickness class 1, Hartenstein GmbH). 
 
 
4.3.3. Labeling 
Labeling was performed by incubating the cells on the cover slips for 30 min at 37oC in 
DMEM (270µl) with 1% Bovine Serum Albumin (BSA, Sigma); 1.5µM 6xHis-PPTase 
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and 0.3nM CdSe/ZnS Quantum Dot – CoA molecules prepared with the 655 Qdot 
Antibody Conjugation Kit (Molecular Probes, Invitrogen). Before measurements samples 
were washed three times with 500 µl DMEM. Experiments were conducted on cells in 
300 µl DMEM. 
 
4.3.4. Peptide Ligands 
The peptide ligands used were as follows: hPTH(1–34), hPTHrP(107–111)NH2; PTH(1–
14); PTH(1–28) bPTH(3–34). The human PTH(1–34) (free carboxy terminus), human 
PTHrP(107-111), and bovine PTH(3-34) was purchased from Bachem California 
(Torrance, CA). The PTH(1–14) and  PTH(1–28)  peptides were synthesized by the 
Massachusetts General Hospital Biopolymer Core facility, as described (ref. MGH). 
Peptide quality was verified by analytical HPLC, matrix-assisted laser 
desorption/ionization mass spectrometry and amino acid analysis, and peptide 
concentrations of stock solutions were established by amino acid analysis. Radiolabeled 
peptide variants were prepared by the oxidative chloramine-T procedure using Na125I 
(specific activity, 2200 Ci/mmol; PerkinElmer/NEN Life Science Products, Boston, MA) 
and were purified by reversed-phase HPLC. 
Ligands were added in concentrations from 250pM to 250µM, with ten-fold increment 
for particular experiments. 
 
4.3.5. Pharmacology 
Ligand binding and measurement of cAMP were performed as described (ref. 
Pharmacology Harvard) with minimal modifications. For binding studies, stably 
transfected cells grown in 24-well plates were incubated in DHB buffer (serum-free 
DMEM containing 20 mM Hepes and 1% BSA) for 1 h at 0°C, followed by a 1.5-h 
incubation with the same buffer containing 125I-PTH(1-34) (100,000 cpm per well) as a 
radioligand with or without varying concentrations of unlabeled peptides. Cells were 
washed three times with iced PBS and extracted with 0.8 M NaOH, and cell-associated 
125I-PTH(1-34) was counted.  
For cAMP assays, cells grown in 12-well plates were washed twice with Hepes buffer 
(137 mM NaCl/5 mM KCl/1 mM CaCl2/1 mM MgCl2/20
 mM Hepes, pH 7.4) and 
incubated with isobutylmethylxanthine (0.5 mM) in the same buffer for 5 min at 37°C. 
Cells were stimulated with varying concentrations of PTH(1-34) or PTH(1-34)TMR at 37°C 
for 15 additional min. Cellular cAMP was extracted and measured by RIA (Immunotech, 
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Luminy, France; Beckman Coulter). Competition binding studies and concentration-
response data were analyzed with the program PRISM 4.0 (GraphPad, San Diego). 
 
4.3.6. Single-molecule microscopy 
accodrding to the point 1.3.5. 
 
4.3.7. Total internal reflection single-molecule microscopy 
accodrding to the point 1.3.6. 
 
4.3.8. Data analysis 
accodrding to the point 1.3.7. 
 
4.3.9. Mobility analysis 
accodrding to the point 1.3.8. 
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Figure 2g-h. Lateral mobility of BMPRII is reduced upon ligand stimulation.                                           (page 38) 
(g,h) Enhanced DRM-association of endogenous BMPRII upon ligand stimulation as assessed by co-fractionation 
with the DRM-marker Caveolin1. C2C12 cells were starved and stimulated with BMP-2 for 5 min. After cell surface 
biotinylation cells were used for sucrose gradient fractionation and subsequent streptavidin precipitation of 
biotinylated proteins. Precipitates were subjected to Western blot analysis. Quantification of Western blot analysis 
demonstrates the increased proportion of BMPRII in DRM-fractions after BMP-2 addition. 
 
Figure 4a-c. Structural components mediating the confined mobility of BMPRIb.                                   (page 42) 
(a) Mutagenesis approach for identification of structural elements responsible for the immobility of BMPRIb. Point 
mutations, a poly-alanine scan of the transmembrane domain and intracellular truncations of BMPRIb were 
generated by targeted mutagenesis. The wild type sequence of transmembrane domain is depicted in black, the 
mutated amino acids in red.  
(b,c) Reduced DRM-association of BMPRIb transmembrane domain (TM) mutants as assessed by co-fractionation of 
receptor with Caveolin1. C2C12-TM2, -TM5 and -PKT cells were used for sucrose gradient fractionation and fractions 
were subjected to Western blot analysis (b). The histogram (c) depicts the percentage of receptor present in DRM-
fractions obtained by quantification of the Western blot analysis. 
 
Figure 5. Effects of enhanced BMPRIb mobility on signaling.                                                                    (page 44) 
(a,b) Western blot analysis of Smad1/5/8, p38 and Akt activation in C2C12-BMPRIb wt, -TM2, -TM5 and -PKT cells. 
Cells were stimulated with BMP-2, GDF-5 or pure PBS for 60 min. Cell lysates were subjected to Western blot 
analysis of respective phosphorylated proteins. GAPDH was used as loading control. Quantification of Western blot 
(b) depicts relative intensity of phospho-specific signals normalized to respective GAPDH.  
(c) Expression analysis of osteoblastic differentiation markers in C2C12-BMPRIb wt or mutant cells. C2C12-BMPRIb 
wt, -TM2, -TM5 and -PKT cells were starved, stimulated with GDF-5 for 12 h or 48 h and used for RNA isolation. 
Quantitative RT-PCR was performed to analyze gene expression of Runx2, ALP, Osterix and OCN. Gene expression 
was normalized to HPRT expression and plotted as mean normalized values (MNE). 
(d) Analysis of Smad-mediated transcriptional activation by BMP-responsive reporter gene assay. Cells were 
transfected with BMP-responsive and constitutive active luciferase constructs, starved and stimulated with GDF-5 for 
6 h. Luciferase activity was measured in cell lysates. Quantification shows GDF-5-induced luciferase activity 
normalized to constitutive luciferase activity. 
(e) Alkaline phosphatase (ALP) activity assay. C2C12 cells-BMPRIb wt, -TM2, -TM5 and -PKT cells were starved and 
stimulated with various concentrations of GDF-5 for 72 h. ALP production indicative for osteoblastic differentiation 
was assessed by a colorimetric assay of enzymatic activity of ALP. 
 
Figure 6a. Increased lateral mobility of receptor does not impair receptor endocytosis.                       (page 46) 
(a) FACS-based analysis of BMPRIb internalization. HA-tagged BMPRIb wt or mutant receptors transiently 
expressed in HEK293T were fluorescently labeled and the decrease of surface fluorescence assessed by FACS-
measurements. The line plot depicts the time-dependent decrease of mean fluorescence indicative of receptor 
internalization. 
 
